Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Stauber Rudolf |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Scheiner, B; Kang, B; Balcar, L; Radu, P; Reiter, FP; Adzic, G; Guo, J; Gao, X; Yuan, X; Cheng, L; Gorgulho, J; Schultheiss, M; Ben Khaled, N; Sinner, F; D'Alessio, A; Pomej, K; Saborowski, A; Schwacha-Eipper, B; Zarka, V; Lampichler, K; Nishida, N; Lee, PC; Krall, A; Saeed, A; Himmelsbach, V; Tesini, G; Wietharn, B; Huang, YH; Vivaldi, C; Masi, G; Vogel, A; Schulze, K; Trauner, M; Stauber, RE; Kudo, M; Dekervel, J; Parikh, N; Dufour, JF; Prejac, J; Geier, A; Bengsch, B; von Felden, J; Venerito, M; Philipp, A; Finkelmeier, F; Ji, FP; Wang, HW; Rimassa, L; Pinato, DJ; Bouattour, M; Chon, HJ; Pinter, M Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy
J HEPATOL. 2024; 80: S69-S69.-EASL Congress; JUN 5-8, 2024; Milan, ITALY. [Oral Communication]
Web of Science

 

Stauber, RE; Rainer, F; Stadlbauer, V; Avian, A; Scharnagl, H; Marsche, G A HDL-based prognostic model performs better than MELD in chronic liver failure
J HEPATOL. 2024; 80: S383-S383.-EASL Congress; JUN 5-8, 2024; Milan, ITALY. [Poster]
Web of Science

 

Balcar, L; Scheiner, B; Fulgenzi, CAM; D'Alessio, A; Pomej, K; Cheon, J; Nishida, N; Lee, PC; Wu, L; Ang, CSP; Krall, A; Saeed, A; Stefanini, B; Cammarota, A; Pressiani, T; Mohamed, YI; Chamseddine, S; Wietharn, B; Parisi, A; Huang, YH; Phen, S; Vivaldi, C; Salani, F; Masi, G; Bettinger, D; Vogel, A; Von Felden, J; Schulze, K; Silletta, M; Trauner, M; Samson, A; Wege, H; Piscaglia, F; Galle, PR; Stauber, RE; Kudo, M; Singal, AG; Ulahannan, S; Parikh, ND; Cortellini, A; Kaseb, A; Rimassa, L; Chon, HJ; Pinato, DJ; Pinter, M SEX-RELATED DIFFERENCES IN EFFICACY AND SAFETY OF IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS OF LANDMARK PHASE III TRIALS AND VALIDATION IN ROUTINE CLINICAL PRACTICE
HEPATOLOGY. 2023; 78: S1888-S1889.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Diaz, LA; Norero, B; Corsi, O; Ayares, G; Idalsoaga, F; García, S; Vázquez, V; Lacalle, L; Lazo, M; Ferreccio, C; Mendizabal, M; Piñero, F; Martinez, E; Ijeoma, I; Louvet, A; Piano, S; Cortez-Pinto, H; Wong, VWS; Kulkarni, A; Cotter, T; Brahmania, M; Roblero, JP; Dirchwolf, M; Pollarsky, F; George, J; Stauber, RE; Francque, S; Guerra, P; Oliveira, C; Araujo, R; Alvares-Da-Silva, M; Blaise, N; Abraldes, JG; Zheng, MH; Toro, L; Restrepo, JC; Ramirez, W; Grgurevic, I; Infante, M; Mbendi, C; Carrera, E; El Kassas, M; Mahmoud, A; Tesfaye, YG; Tadesse, SA; Akalu, TF; Desalegn, H; Allaire, M; Patrizia, C; Schattenberg, J; Aguyire, J; Micah, EA; Tachi, K; Cardona, KEM; Sanchez, A; Sánchez, M; Björnsson, ES; Iavarone, M; Okamoto, R; Some, F; Hellani, MF; Gonzalez, VEP; Chávez-Tapia, NC; Méndez-Sánchez, N; Mucumbi, SCM; Ugiagbe, RA; Akande, K; Nwoko, C; Ezenkwa, US; Okoye, IJ; Hamid, SS; Quezada, JL; Girala, M; Padilla, PM; Diaz-Ferrer, J; Tagle, M; Kukla, M; Odeghe, E; Wemimo, RM; Reis, D; Mozgovoi, S; Ismail, M; Koller, T; Spearman, W; Elhassan, M; Stal, P; Pazi, S; Ocanit, A; Masson, S; Dunn, W; Kamath, PS; Singal, A; Debes, J; Reig, M; Loomba, R; Bataller, R; Lazarus, J; Arrese, M; Arab, JP Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma
J HEPATOL. 2023; 78: S865-S867. [Poster]
Web of Science

 

Jörg, V; Scheiner, B; D'Alessio, A; Fulgenzi, C; Schoenlein, M; Kocheise, L; Lohse, AW; Huber, S; Wege, H; Kaseb, A; Wang, YH; Muzaffar, M; Abugabal, Y; Chamseddine, S; Phen, S; Cheon, J; Lee, PC; Balcar, L; Krall, A; Ang, C; Wu, L; Saeed, A; Huang, YH; Bengsch, B; Rimassa, L; Weinmann, A; Stauber, RE; Korolewicz, J; Pinter, M; Singal, A; Chon, HJ; Pinato, DJ; Schulze, K; von Felden, J Efficacy and tolerability of atezolizumab and bevacizumab in patients with hepatocellular carcinoma previously treated with systemic therapy: a global, observational study
J HEPATOL. 2023; 78: S582-S582. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, G; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar, D; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S932-S935.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Dr Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE
HEPATOLOGY. 2023; 78: S995-S998.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Dr Shalimar; Hagström, SH; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S1018-S1020.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD
HEPATOLOGY. 2023; 78: S971-S974.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S928-S931.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Oettl, K; Paar, M; Fengler, VH; Reibnegger, G; Schnurr, K; Waterstradt, K; Boss, K.; Kribben, A; Stauber, RES Structural and functional properties of human serum albumin
ESBRA; 2023. [Oral Communication]

 

Paar, M; Fengler, VH; Reibnegger, G; Schnurr, K; Waterstradt, K; Schwaminger, SB; Stauber, RE; Oettl K Effective albumin concentration is mainly determined by reversible factors
19th European Society for Biomedical Research on Alcoholism Conference 2023; SEP 1-3, 2023; Graz, Austria. 2023. [Poster]

 

Paar, M; Fengler, VH; Reibnegger, G; Schnurr, K; Waterstradt, K; Schwaminger, SP; Stauber, RE; Oettl, K EFFECTIVE ALBUMIN CONCENTRATION IN CHRONIC LIVER FAILURE IS DETERMINED MAINLY BY REVERSIBLE FACTORS: POSSIBLE THERAPEUTIC CONSEQUENCES
HEPATOLOGY. 2023; 78: S1965-S1966.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Pennisi, G; Enea, M; Falco, V; Aithal, GP; Palaniyappan, N; Yilmaz, Y; Boursier, J; Cassinotto, C; De Lédinghen, V; Chan, WK; Mahadeva, S; Eddowes, P; Newsome, P; Karlas, T; Wiegand, J; Wong, VWS; Schattenberg, JM; Labenz, C; Kim, W; Lee, MS; Lupsor-Platon, M; Cobbold, JFL; Fan, J; Shen, F; Staufer, K; Trauner, M; Stauber, R; Nakajima, A; Yoneda, M; Bugianesi, E; Younes, R; Gaia, S; Zheng, M; Cammà, C; Anstee, QM; Mózes, FE; Pavlides, M; Petta, S Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
DIGEST LIVER DIS. 2023; 55: S12-S13. Doi: 10.1016/j.dld.2023.01.022 [Oral Communication]
Web of Science FullText FullText_MUG

 

Scheiner, B; Sartoris, R; D'Alessio, A; Fulgenzi, C; Pomej, K; Balcar, L; Bouattour, M; Sidali, S; Himmelsbach, V; Finkelmeier, F; Schulze, K; von Felden, J; Hucke, F; Shmanko, K; Siebenhüner, A; Mertens, JC; De Dosso, S; Ebert, M; Teufel, A; Waldschmidt, DT; Radu, IP; Krall, A; Trauner, M; Dufour, JF; Wege, H; Weinmann, A; Trojan, J; Stauber, RE; Peck-Radosavljevic, M; Hsu, WF; Vogel, A; Ronot, M; Pinato, DJ; Pinter, M Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
J HEPATOL. 2023; 78: S491-S492. [Poster]
Web of Science

 

Fandler-Höfler, S; Kneihsl, M; Stauber, RE; Mangge, H; Wünsch, G; Haidegger, M; Fickert, P; Enzinger, C; Gattringer, T LIVER FIBROSIS IS RELATED TO ATRIAL FIBRILLATION AND OUTCOME IN ACUTE ISCHEMIC STROKE
European Stroke Journal, ESOC 2022 Abstract Book. 2022; -8th European Stroke Organisation Conference; May 4-6, 2022; Lyon, France. [Oral Communication]

 

Ferenci, P; Mohr, I; Staettermayer, A; Stauber, RE; Panzer, M; Steindl-Munda, PE; Merle, U; Trauner, MH; Weiss, KH TETRAETHYLENTETRAMIN AS FIRST LINE TREATMENT OF WILSON DISEASE - LONG-TERM RESULTS
HEPATOLOGY. 2022; 76: S1121-S1122.-AASLD Annual Meeting; NOV 4-8, 2022; Washington, DC. [Poster]
Web of Science

 

Krall, A; Matejka, J; Godschachner, T; Posch, A; Stauber, RE Comparison of CRAFITY and PROSASH-II for prediction of survival in patients with hepatocellular carcinoma treated with sorafenib.
. 2022; -55. Jahrestagung & 32. Fortbildungskurs ÖGGH; SEP 7-9, 2022; Vienna, AUSTRIA. [Poster]

 

Madl, T; Kerbl-Knapp, J; Rainer, F; Douschan, P; Stadlbauer, V; Avian, A; Marsche, G; Claria, J; Stauber, RE A novel metabolomics-based prognostic model shows superior diagnostic accuracy than MELD in chronic liver failure
J HEPATOL. 2022; 77: S346-S346.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

Munda, P; Tulaeva, I; Stauber, RE; Gattringer, P; Trauner, M; Brunar, H; Valenta, R; Ferenci, P Induction of pre-s antobodies in HBeAg negative chronic hepatitis B patients by thereupatic vaccination with the pre-s based vaccine VVX001-interim analysis
J HEPATOL. 2022; 77: S854-S854.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

Paar, M; Fengler, VH; Reibnegger, G; Schnurr, K; Waterstradt, K; Stauber, RE; Boss, K; Kribben, A; Oettl, K Effective albumin: binding characteristics determined by different methods
ESAO Abstract Book 48th Annual Congress. 2022; 45(9):-48th Annual ESAO Congress; SEP 6-10, 2022; Krems, AUSTRIA. Doi: 10.1177/03913988221117047 [Oral Communication]
Web of Science FullText FullText_MUG

 

Simao, AL; Palma, CS; Izquierdo-Sanchez, L; Putignano, A; Carvalho-Gomes, A; Posch, A; Zanaga, P; Girleanu, I; Araujo, C; Delphine, D; Gustot, T; Sahuco, I; Spagnolo, E; Carvalhana, S; Moura, M; Henrique, MM; Fernandes, DAE; Marques, F; Banales, JM; Gomez, MR; Trifan, A; Russo, FP; Stauber, RE; Berenguer, M; Moreno, C; Goncalves, J; Cortez-Pinto, H; Castro, R Presence of cirrhosis in chronic liver disease patients associates with a lower immune response to COVID-19 vaccines-a multicenter european study
J HEPATOL. 2022; 77: S192-S192.-EASL Annual Meeting; JUN 22-26, 2022; [Poster]
Web of Science

 

Staufer, K; Huber, H; Zessner-Spitzenberg, J; Stauber, RE; Finkenstedt, A; Bantel, H; Weiss, T; Huber, M; Starlinger, P; Grunberger, T; Reiberger, T; Sebens, S; McIntyre, G; Tabibiazar, R; Giaccia, A; Zoller, H; Trauner, M; Mikulits, W Large-scale multicenter study for the clinical utility of the non-invasive biomarkers Gas6 and soluble Axl in hepatocellular carcinoma, liver fibrosis and end-stage liver disease
J HEPATOL. 2022; 77: S470-S470.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

Fandler-Hofler, S; Stauber, R; Kneihsl, M; Wunsch, G; Haidegger, M; Poltrum, B; Pichler, A; Deutschmann, H; Enzinger, C; Fickert, P; Gattringer, T Liver fibrosis is associated with atrial fibrillation and worse outcome in large vessel occlusion stroke
EUR J NEUROL. 2021; 28: 151-151.-7th Congress of the European Academy of Neurology; June 19-22, 2021; Vienna, Austria. [Oral Communication]
Web of Science

 

Fandler-Höfler, S; Stauber, R; Kneihsl, M; Wünsch, G; Haidegger, M; Poltrum, B; Pichler, A; Deutschmann, H; Enzinger, C; Fickert, P; Gattringer, T SUBCLINICAL LIVER FIBROSIS RELATES TO POOR PROGNOSIS IN PATIENTS TREATED WITH MECHANICAL THROMBECTOMY
European Stroke Journal. 2021; 6(1_supp):-European Stroke Organisation Conference; SEPT 1-3, 2021; Helsinki, Finland. [Onlinepräsentation]
FullText

 

Mozes, F; Lee, J; Selvaraj, E; Jayaswal, A; Trauner, M; Boursier, J; Fournier, C; Staufer, K; Stauber, R; Bugianesi, E; Younes, R; Gaia, S; Lupsor-Platon, M; Petta, S; Shima, T; Okanoue, T; Mahadeva, S; Chan, WK; Eddowes, P; Newsome, PN; Wong, VWS; de Ledinghen, V; Fan, JG; Shen, F; Cobbold, J; Sumida, Y; Okajima, A; Schattenberg, J; Labenz, C; Kim, W; Lee, MS; Wiegand, J; Karlas, T; Yilmaz, Y; Aithal, G; Palaniyappan, N; Cassinotto, C; Aggarwal, S; Harshit, G; Ooi, G; Nakajima, A; Yoneda, M; Ziol, M; Barget, N; Geier, A; Tunill, T; Brosnan, MJ; Anstee, Q; Neubauer, S; Harrison, S; Bossuyt, P; Pavlides, M Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis
J HEPATOL. ILC 2021 Abstracts. 2021; 75: S259-S260.-The International Liver Congress; JUN 23-26, 2021; Virtuell. [Poster]
Web of Science

 

Altekruse, A; Kovacs, G; Sassmann, T; Foris, V; Avian, A; Stadlbauer, V; Stauber, R; Olschewski, H; Douschan, P Pulmonary exercise hemodynamics in patients with liver cirrhosis - a stress echocardiography study.
EUR RESPIR J. 2020; 56: Doi: 10.1183/13993003.congress-2020.1513 [Poster]
Web of Science FullText FullText_MUG

 

Negrean, I; Stadlbauer-Köllner, V; Horvath, A; Feldbacher, N; Posch, A; Streit, A; Stauber, R Fibroscan® probe selection for lean adults.
Zeitschrift für Gastroenterologie / German Journal of Gastroenterology 2020. 2020; (58):e92-e92.-53. ÖGGH Jahrestagung 2020; JUN 18-19, 2020; Vienna, AUSTRIA. [Poster]

 

Sourij, C; Stauber, R; Aziz, F; Kojzar, H; Obermayer, A; Pferschy, P; Tripolt, N; Aberer, F; Sourij, H NAFLD in Patients with Diabetes mellitus and Lipid Metabolism Disorders: Data from the Graz Diabetes Registry for Biomarker Research GIRO.
WIEN KLIN WOCHENSCHR. 2020; 132: S344-S345. [Poster]
Web of Science

 

Dietz, J; de Salazar, A; Vermehren, J; Merino, D; zur Wiesch, JS; Lara, M; Pardo, MJR; Di Maio, VC; Paolucci, S; Degasperi, E; Zoller, H; Ruiz-Tapiador, JIA; Stauber, RE; Figueruela, B; Buti, M; Lampertico, P; Zeuzem, S; Silberstein, FC; Garcia, FG; Sarrazin, C Clinical and virological characteristics of patients with chronic hepatitis C and failure to voxilaprevir/velpatasvir/sofosbuvir treatment
J HEPATOL. 2019; 70: E219-E220.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)30409-8 [Poster]
Web of Science FullText FullText_MUG

 

Dietz, J; Vermehren, J; Peiffer, KH; Wietzke-Braun, P; Muellhaupt, B; Schattenberg, J; Antoni, C; Hametner, S; Mauss, S; Heinzow, H; Graf, C; Port, K; Rockstroh, JK; Zoller, H; Zizer, E; Herrmann, A; Zur Wiesch, JS; Mueller, T; Stauber, RE; Kremer, A; Berg, C; Zeuzem, S; Sarrazin, C CLINICAL AND VIROLOGICAL CHARACTERISTICS AND RETREATMENT OF HCV-INFECTED PATIENTS WITH FAILURE TO MULTIPLE SUBSEQUENT DAA THERAPIES
HEPATOLOGY. 2019; 70: 937A-938A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

Fengler, VHI; Paar, M; Rosenberg, D; Stauber, R; Hammel, M; Krebs, A; Oettl, K Structural analyzes of human serum albumin in acute-on-chronic liver failure by SEC-SAXS.
International SAXS Symposium 2019: SAXS excites; SEP 24-24, 2019; Graz, AUSTRIA. 2019. [Poster]

 

Garcia, FG; Dietz, J; Di Maio, VC; Vermehren, J; De Salazar, A; Paolucci, S; Mullhaupt, B; Coppola, N; Cabezas, J; Stauber, RE; Puoti, M; Ruiz-Tapiador, JIA; Aragri, M; Jimenez, M; Callegaro, A; Acevedo, JMP; Rodriguez, MAM; Zabal, JMR; Micheli, V; Gomez, N; Tellez, F; Sarrazin, C; Silberstein, FC CLINICAL AND VIROLOGICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C AND FAILURE TO A GLECAPREVIR AND PIBRENTASVIR (G/P) TREATMENT IN REAL WORLD
HEPATOLOGY. 2019; 70: 998A-999A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

Horvath, A; Durdevic, M; Leber, B; di Vora, K; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V Changes in the intestinal microbiome during probiotic intervention in cirrhosis
J HEPATOL. 2019; 70: E648-E648.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)31290-3 [Poster]
Web of Science FullText FullText_MUG

 

Horvath, A; Durdevic, M; Leber, B; di Vora, KG; Rainer, F; Douschan, P; Krones, E; Spindelböck, W; Baumann-Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V: The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis
Z Gastroenterol 2019; 57(05): e158 DOI: 10.1055/s-0039-1691924. 2019; -Jahrestagung der ÖGGH; JUN 13-15, 2019; Innsbruck, Austria. [Poster]

 

Komarova, I; Leber, B; Horvath, A; Posch, A; Streit, A; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V Improvement of neutrophil function in hepatitis C patients under direct acting anti-viral treatment is associated with hemolysis parameters
J HEPATOL. Journal of Hepatology. 2019; 70(1):E226-E226.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)30422-0 [Poster]
Web of Science FullText FullText_MUG

 

Komarova, I; Leber, B; Horvath, A; Posch, A; Streit, A; Spindelboeck, W; Stiegler, P; Stauber, R; Stadlbauer, V. Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment
Zeitschrift für Gastroenterologie. 2019; 57(05):e161-e162.-52. Jahrestagung & 30. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH); JUN 13-15, 2019; Innsbruck, AUSTRIA. [Poster]
FullText

 

Paternostro, R; Pfeiffenberger, J; Ferenci, P; Stattermayer, A; Wrba, F; Longerich, T; Lackner, C; Stauber, RE; Trauner, MH; Ferlitsch, A; Weiss, KH LONG TERM DISEASE MONITORING USING TRANSIENT ELASTOGRAPHY IN PATIENTS WITH BIOPSY-PROVEN WILSON DISEASE
HEPATOLOGY. 2019; 70: 1179A-1180A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

Rosenberg, D; Fengler, VH; Paar, M; Stauber, R; Hammel M; Krebs, A; Oettl, K Structural analyzes of human serum albumin in acute-on-chronic liver failure by SEC-SAXS
https://www.medunigraz.at/international-student-congress/program-2019/abstract-book-2019/. 2019; -International Student Congress ISC 2019; May 30 - Jun 1, 2019; Graz, Austria. [Oral Communication]

 

Stauber, RE; Kaferbock, P; Spindelbock, W; Douschan, P; Rainer, F; Lackner, C Quantitative fibrosis assessment independently predicts outcome in alcoholic liver disease
J HEPATOL. 2019; 70: E286-E286.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)30547-X [Poster]
Web of Science FullText FullText_MUG

 

Stauber, RE; Marculescu, R; Obermayer-Pietsch, B; Eilenberg, M; Lackner, C; Cales, P; Trauner, MH; Staufer, K FibroMeter(VCTE) SHOWS SUPERIOR DIAGNOSTIC ACCURACY FOR NONINVASIVE DIAGNOSIS OF FIBROSIS STAGE IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD).
HEPATOLOGY. 2019; 70: 1059A-1059A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

Ventura-Cots, M; Argemi, J; Jones, PD; Lackner, K; Abraldes, JG; Alves, A; Alboraie, MA; Altamirano, J; Bosques, FJ; Brown, RS; Caballeria, J; Cabezas, J; Cortez-Pinto, H; Costa, A; Degre, D; El Hag, M; Fernandez-Carrillo, C; Ganne, N; Garcia-Tsao, G; Genesca, J; Koskinas, J; Lanthier, NGG; Louvet, A; Lozano, JJ; Lucey, MR; Masson, S; Mathurin, P; Mendez-Sanchez, N; Miquel, R; Moreno, C; Mounajjed, T; Odena, G; Sancho-Bru, P; Sempoux, C; Straub, BK; Stauber, RE; Tiniakos, D; Blasco, VMV; Verna, E; Verset, L; Kim, W; Woosley, J; Ziol, M; Mueller, S; Starkel, P; Shah, V; Bataller, R MOLECULAR PROFILING OF HUMAN ALCOHOLIC HEPATITIS VS EARLY ALCOHOLIC STEATOHEPATITIS REVEALS PROFOUND UP-REGULATION OF EPITHELIAL-TO-MESENCHYMAL TRANSITION PATHWAY
HEPATOLOGY. 2019; 70: 820A-822A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 08-12, 2019; Boston, MA. [Poster]
Web of Science

 

Alcaraz-Quiles, J; Casulleras, M; Oettl, K; Titos, E; Flores-Costa, R; Duran-Guell, M; Lopez-Vicario, C; Pavesi, M; Stauber, RE; Arroyo, V; Claria, J Oxidized albumin triggers a cytokine/eicosanoid storm in leukocytes through p38 MAP kinase: role in systemic inflammation in decompensated cirrhosis
EUR J CLIN INVEST. 2018; 48: 78-78.-52th Annual Scientific Meeting of the European Society for Clinical Investigation; MAY 30 - JUN 1; Barcelona, SPAIN. [Poster]
Web of Science

 

Claria, J; Moreau, R; Fenaille, F; Amoros, A; Junot, C; Gronbaek, H; Coenraad, M; Oettl, K; Caraceni, P; Alessandria, C; Trebicka, J; Pavesi, M; Gomez, CD; Albillos, A; Gustot, T; Welzel, T; Fernandez, J; Stauber, RE; Saliba, F; Butin, N; Colsch, B; Moreno, C; Durand, F; Nevens, F; Banares, R; Benten, D; Gines, P; Gerbes, A; Jalan, R; Angeli, P; Bernardi, M; Arroyo, V The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality
J HEPATOL. 2018; 68: S120-S121.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. [Poster]
Web of Science

 

Ferenci, P; Pfeiffenberger, J; Stattermayer, A; Stauber, RE; Willheim, C; Weiss, KH; Trauner, MH; Zoller, H Is the HSD17B13 Variant a Genetic Modifier of Wilson Disease?
HEPATOLOGY. 2018; 68: 721A-721A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

Horvath, A; Durdevic, M; Leber, B; di Vora, KG; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V Changes in the intestinal microbiome during a multispecies probiotic intervention in compensated cirrhosis
Theodor Escherich Symposium; NOV 8-9, 2018; Graz, Austria. 2018. [Poster]

 

Horvath, A; Rainer, F; Leber, B; Schmerböck, B; Spindelböck, W; Stauber, RE; Stiegler, P; Stadlbauer, V AGRA – a functional biomarker for humoral immune function predicts the development of severe bacterial infections in cirrhosis
Z Gastroenterol 2018; 56(05): e38. 2018; -Jahrestagung der Österreichischen Gesellschaft der Gastroenterologie und Hepatologie; JUN 14-16, 2018; Salzburg, Austria. [Poster]

 

Horvath, A; Rainer, F; Leber, B; Schmerboeck, B; Spindelboeck, W; Stauber, R; Stiegler, P; Stadlbauer, V ACELLULAR GROWTH RETARDATION ABILITY (AGRA) PREDICTS THE OCCURRENCE OF SEVERE BACTERIAL INFECTIONS IN CIRRHOSIS.
TRANSPL INT. 2018; 31: 8-9. [Poster]
Web of Science

 

Komarova, I; Horvath, A; Krones, E; Fickert, P; Leber, B; Schmerböck, B; Durchschein, F; Zollner, G; Stauber, R; Spindelboeck, W; Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Stadlbauer, V Bile acids composition and neutrophil function in different etiologies of liver cirrhosis.
JOINT DK-RETREAT MCBO/MOLIN/IAI “Cancer, Inflammation, Immunity”; JAN 13-17, 2018; Universitätszentrum OBERGURGL, Tirol, AUSTRIA. 2018. [Poster]

 

Komarova, I; Horvath, A; Krones, E; Leber, B; Schmerboeck, B; Durchschein, F; Zollner, G; Stauber, R; Spindelboeck, W; Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Fickert, P; Stadlbauer, V Functional response of neutrophils is associated with serum bile acids profile in liver cirrhotic patients
Zeitschrift für Gastroenterologie. 2018; 56(05):e28-e28.-51. ÖGGH Jahrestagung; JUN 14–16, 2018; Salzburg, AUSTRIA. [Oral Communication]
FullText

 

Komarova, I; Horvath, A; Krones, E; Leber, B; Schmerboeck, B; Durchschein, F; Zollner, G; Stauber,RE; Spindelböck, W; Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Stadlbauer, V Changes of bile acids profile in different etiologies of liver cirrhosis and its association with neutrophil response
JOURNAL OF HEPATOLOGY. 2018; 68(SUPP.1):S473-S473.-The International Liver Congress; APR 11–15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31193-0 [Poster]
Web of Science FullText FullText_MUG

 

Kozbial, K; Al-Zoairy, R; Schaefer, B; Gschwantler, M; Stauber, RE; Hametner, S; Maieron, A; Laferl, H; Strasser, M; Hayat-Khayyati, A; Datz, C; Kramer, L; Graziadei, I; Stattermayer, A; Beinhardt, S; Munda, P; Zoller, H; Trauner, M; Hofer, H; Ferenci, P Real world experience of retreatment of chronic hepatitis C patients who failed IFN-free DAA therapy
J HEPATOL. 2018; 68: S279-S280.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)30776-1 [Poster]
Web of Science FullText FullText_MUG

 

Lackner, K; Binder, L; Rainer, F; Stauber, RE Morphometrical quantification of fibrosis correlates with clinical cirrhosis stage and predicts long-term survival in patients with alcoholic liver disease
J HEPATOL. 2018; 68: S815-S815.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31903-2 [Poster]
Web of Science FullText FullText_MUG

 

Leber, B; Horvath, A; Schmerboeck, B; Posch, A; Streit, A; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V Direct acting anti-viral therapy rescues neutrophil dysfunction in hepatitis C infection by reduction of heamolysis
J HEPATOL. 2018; 68: S326-S327.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)30873-0 [Poster]
Web of Science FullText FullText_MUG

 

Leber, B; Horvath, A; Schmerboeck, B; Posch, A; Streit, A; Spindelboeck, W; Stiegler, P; Stauber, RE; Stadlbauer, V Direct acting anti-viral therapy rescues neutrophil dysfunction in HCV infection.
Journal of Hepatology, Volume 68, Supplement 1, S1-S926. 2018; 68(Suppl1):326-327.-The International Liver Congress, 2018; APR 11-18, 2018; Paris, France. [Poster]

 

Paternostro, R; Pfeiffenberger, J; Stattermayer, A; Stauber, RE; Trauner, MH; Ferenci, P; Ferlitsch, A; Weiss, KH Transient Elastography, APRI and FIB-4 Scores for Staging of Fibrosis and Cirrhosis in Wilson Disease
HEPATOLOGY. 2018; 68: 725A-726A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

Pollheimer, M; Racedo, S; Mikels-Vigdal, A; Bowlus, C; Lackner, C; Karlsen, TH; Hov, JR; Lyman, SK; Adamkewicz, J; Smith, V; Moreau, E; Eide, TJ; Stojakovic, T; Stauber, RE; Trauner, M; Fickert, P Lysyl oxidase-like protein 2 in cholangiopathies
VIRCHOWS ARCH. 2018; 473: S6-S7.-30th European Congress of Pathology; 08-12.09, 2018 ; Bilbao. [Oral Communication]
Web of Science

 

Quiles, JA; Casulleras, M; Oettl, K; Titos, E; Flores-Costa, R; Lopez-Vicario, C; Duran-Guell, M; Pavesi, M; Stauber, RE; Arroyo, V; Claria, J Oxidized albumin present in patients with decompensated cirrhosis triggers the inflammatory response in peripheral leukocytes through the p38 MAP kinase pathway
J HEPATOL. 2018; 68: S10-S10.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)30237-X [Oral Communication]
Web of Science FullText FullText_MUG

 

Rainer, F; Horvath, A; Bashir, M; Leber, B; Schmerboeck, B; Blesl, A; Madl, T; Klymiuk, I; Groselj-Strele, A; Durdevic, M; Gronbaek, H; Moller, HJ; Freedber, DE; Abrams, JA; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V Loss of colonization resistance in cirrhosis facilitates proton pump inhibitor-associated oralization of the colonic microbiome
J HEPATOL. 2018; 68: S700-S700.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31663-5 [Poster]
Web of Science FullText FullText_MUG

 

Sassmann, T; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Revelant, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P Diastolic dysfunction and cardiopulmonary exercise capacity in patients with advanced liver disease-results from a prospective cross-sectional cohort
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):627-627.-ÖGP Jahrestagung; OKT 18-20, 2018; Linz, Austria. [Poster]
Web of Science

 

Sassmann, T; Kovacs, G; Stauber, RE; Revelant, F; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P; Impact of diastolic dysfunction on exercise capacity in patients with liver cirrhosis
European Respiratory Journal. 2018; 52(sup 62):-ERS International Congress; SEP 15 - 19, 2018; Paris, France. Doi: 10.1183/13993003.congress-2018.PA2486 [Poster]
Web of Science FullText FullText_MUG

 

Stauber, RE; Staufer, K; Stift, J; Marculescu, R; Obermayer-Pietsch, B; Trauner, M; Lackner, K Enhanced liver fibrosis (ELF) score accurately detects advanced fibrosis in nonalcoholic fatty liver disease (NAFLD)
J HEPATOL. 2018; 68: S563-S563.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31383-7 [Poster]
Web of Science FullText FullText_MUG

 

Staufer, K; Marculescu, R; Obermayer-Pietsch, B; Stift, J; Lackner, K; Trauner, MH; Stauber, RE Evaluation and Comparison of Four Noninvasive Tests for Detection of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)
HEPATOLOGY. 2018; 68: 1308A-1309A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA. [Poster]
Web of Science

 

Alcaraz-Quiles, J; Casulleras, M; Oettl, K; Flores-Costa, R; Duran-Guell, M; Lopez-Vicario, C; Titos, E; Stauber, RE; Arroyo, V; Claria, J Oxidized plasma albumin present in patients with decompensated cirrhosis triggers the inflammatory response in innate immune cells
HEPATOLOGY. 2017; 66: 282A-282A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC. [Poster]
Web of Science

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Kloters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl identifies patients at higher risk for hepatocellular carcinoma development: results from a large scale multicenter analysis
J HEPATOL. 2017; 66(1):S626-S626.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31697-5 [Poster]
Web of Science FullText FullText_MUG

 

Douschan, P; Kovacs, G; Stadlbauer, V; Kniepeiss, D; Krones, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Zollner, G; Avian, A; Fickert, P; Olschewski, A; Olschewski, H; Stauber, RE Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension - results from a prospective cross-sectional study
J HEPATOL. 2017; 66(1):S568-S569.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31556-8 [Poster]
Web of Science FullText FullText_MUG

 

Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Sassmann, T; Revelant, F; Stadlbauer, V; Kniepeiss, D; Fickert, P; Avian, A; Olschewski, A; Olschewski, H Impact of chronic liver disease on pulmonary hemodynamics and exercise tolerance - results from a prospective cross-sectional study
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):768-769. [Poster]
Web of Science

 

Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer-Kollner, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H Exercise Hemodynamics In The Screening For Pulmonary Vascular Disease In Patients With Portal Hypertension - Results From A Prospective Cross-Sectional Study
AM J RESP CRIT CARE. 2017; 195: -International Conference of the American-Thoracic-Society (ATS); MAY 19-24, 2017; Washington, USA. [Oral Communication]
Web of Science

 

Horvath, A; Bashir, M; Schmerboeck, B; Rainer, F; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Leber, B; Stadlbauer, V Intestinal colonisation by Veillonella spp. is predictive for mortality in stable cirrhosis and could be partially reduced by a multispecies probiotic in a randomized placebo controlled trial
J HEPATOL. 2017; 66(1):S128-S128.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30524-X [Poster]
Web of Science FullText FullText_MUG

 

Horvath, A; Durdevic, M; Leber, B; Schmerboeck, B; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer V Multispecies probiotic enriches the microbiome with Lactobacillus and Lactococcus and reduces Enterococcus abundance in patients with liver cirrhosis: Results of a randomized, double-blind, placebo-controlled trial.
Volume 5, Issue 5_suppl, October 2017. 2017; -UEG Week 2017; OCT 28-NOV 1, 2017; Barcelona. [Poster]

 

Leber, B; Horvath, A; Schmerbock, B; Tawdrous, M; Streit, A; Posch, A; Fickert, P; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C
J HEPATOL. 2017; 66(1):S293-S293.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30902-9 [Poster]
Web of Science FullText FullText_MUG

 

Leber, B; Horvath, A; Schmerböck, B; Tawdrous, M; Streit, A; Posch, A; Fickert, P; Spindelböck, W; Stiegler, P; Stauber, RE; Stadlbauer, V Neutrophil phagocytic capacity in chronic hepatitis C improves under direct acting antivirals
Zeitschrift für Gastroenterologie. 2017; 55(5):-ÖGGH; JUN 8-10, 2017; Linz, Austria. [Poster]

 

Oettl, K; Fengler, V; Paar, M; Lemesch, S; Enzendorfer, J; Deak, A; Lirscher, M; Partl, R; Stauber, R Redox state of human serum albumin under different pathologies and interventions
Gordon Research Conference "Oxidative Stress and Disease"; MARCH 19-24, 2017; Barga, Italy. 2017. [Poster]

 

Rainer, F; Horvath, A; Sandahl, TD; Leber, B; Schmerboeck, B; Blesl, A; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Moller, HJ; Gronbaek, H; Stadlbauer, V Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis
J HEPATOL. 2017; 66(1):S368-S369.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31080-2 [Poster]
Web of Science FullText FullText_MUG

 

Schaffellner, S; Stauber, R; Sereinigg, M; Müller, H; Fickert, P; Högenauer, C; Krumnikl, J; Lackner, C; Stadlbauer, V; Kniepeiss, D Akutes Leberversagen nach Vitamin B3 Überdosierung
Chirurgische Forschungsberichte. 2017; -41. Seminar der Österreichischen Gesellschaft für Chirurgische Forschung; NOV, 16-18; Schladming. [Oral Communication]

 

Stadlbauer, V; Schmerbock, B; Leber, B; Kipperer, M; Stiegler, P; Posch, A; Streit, A; Spindelbock, W; Fickert, P; Stauber, R Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C
J HEPATOL. 2017; 66(1):S710-S711.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31903-7 [Poster]
Web of Science FullText FullText_MUG

 

Stauber, RE; Spindelboeck, W; Rainer, F; Douschan, P; Lackner, C Prognostic Value of Liver Histology in "Low-Risk" Alcoholic Liver Disease (Maddrey Score < 32)
HEPATOLOGY. 2017; 66: 710A-711A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC. [Poster]
Web of Science

 

Stauber, RE; Spindelboeck, W; Rainer, F; Douschan, P; Lackner, C Clinical criteria are of limited value for diagnosis of alcoholic steatohepatitis
J HEPATOL. 2017; 66(1):S116-S116.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30494-4 [Oral Communication]
Web of Science FullText FullText_MUG

 

Stauber, RE; Spindelboeck, W; Rainer, F; Douschan, P; Lackner, C PROGNOSTIC VALUE OF LIVER HISTOLOGY IN "LOW-RISK" ALCOHOLIC LIVER DISEASE (MADDREY SCORE < 32)
ALCOHOL ALCOHOLISM. 2017; 52: [Poster]
Web of Science

 

Vermehren, J; Dietz, J; Susser, S; Schott, E; Schattenberg, JM; Zizer, E; Wiesch, JSZ; Antoni, C; Wietzke-Braun, P; Niederau, C; Mauss, S; Rockstroh, JK; Mullhaupt, B; Stauber, RE; Zeuzem, S; Sarrazin, C Failure to multiple Interferon-free direct antiviral therapies: could chronic hepatitis C become incurable?
HEPATOLOGY. 2017; 66: 859A-859A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC. [Poster]
Web of Science

 

Amouzadeh-Ghadikolai, O; Baranyi, A; Meinitzer, A; Breitenecker, RJ; Stauber, R; Rothenhausler, HB New insights in the kynurenine pathway of interferon-alpha-induced depression
EUR NEUROPSYCHOPHARM. 2016; 26: S390-S391.-29th Congress of the European-College-of-Neuropsychopharmacology (ECNP); SEP 17-20, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

 

Beinhardt, S; Al-Zoairy, R; Freissmuth, C; Kozbial, K; Stern, R; Stattermayer, AF; Zoller, H; Maieron, A; Stauber, R; Staufer, K; Strasser, M; Vogel, W; Peck-Radosaljevic, M; Trauner, M; Ferenci, P; Hofer, H; SAFETY AND EFFICACY OF IFNANDRBV-FREE DAA-BASED REGIMENS IN HCV-RECURRENCE AFTER ORTHOTOPIC LIVER TRANSPLANTATION.
J HEPATOL. 2016; 64: S818-S818. Doi: 10.1016/S0168-8278(16)01599-3 [Poster]
Web of Science FullText FullText_MUG

 

Grgic-Mustafic, R; Kahn, J; Podbregar, M; Holobar, A; Stauber, R; Fickert, P; Stadlbauer-Kollner, V; Nwoha, B; Muller, H; Kniepeiss, D A NEW METHOD FOR THE DETERMINATION AND MONITORING OF THE AMMONIA IN THE EXHALED AIR
TRANSPL INT. .. 2016; 29: 18-18. [Poster]
Web of Science

 

Gschwantler, M; Ferenci, P; Bauer, BJ; Laferl, H; Bamberger, T; Stauber, RE; Graziadei, I; Hettinger, J; Teskey, A; Maieron, A Burden of disease in patients with chronic hepatitis C in the Austrian REAL Study
HEPATOLOGY. 2016; 63(1 SUPP):466A-467A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA. [Poster]
Web of Science

 

Horvath, A; Bashir, M; Leber, B; Schmerboeck, B; Tawdrous, M; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V Probiotic modulation of gut microflora in cirrhosis: Influence on Lactobacilli and Veillonella
Microbiome Science Days; OCT 7-8, 2016; Bertesgaden, Germany. 2016. [Oral Communication]

 

Horvath, A; Leber, B; Fuchs, D; Schmerboeck, B; Tawdrous, M; Yueksel, O; Sherzay, K; Hartl, A; Lemesch, S; Spindelboeck, W; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Stadlbauer, V Multispecies probiotic maintains health related quality of life in cirrhosis better than placebo
Journal of Hepatology. 2016; 64(2):425-629.-EASL - ILC2016; APR 12-17, 2016; Barcelona, SPAIN. [Poster]

 

Horvath, A; Leber, B; Fuchs, D; Schmerboeck, B; Tawdrous, M; Yueksel, O; Sherzay, K; Hartl, A; Lemesch, S; Spindelboeck, W; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Stadlbauer, V; MULTISPECIES PROBIOTIC MAINTAINS HEALTH RELATED QUALITY OF LIFE IN CIRRHOSIS BETTER THAN PLACEBO.
J HEPATOL. 2016; 64: S249-S249.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00262-2 [Poster]
Web of Science FullText FullText_MUG

 

Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Zettel, G; Hartl, A; Madl, T; Stryeck, S; Fuchs, D; Lemesch, S; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Rainer, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V A multispecies probiotic enhances antimicrobial activity in cirrhosis: A randomized, double blind placebo-controlled study
Zeitschrift für Gastroenterologie . 2016; (5):385-520.-Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 16-18, ; Wien. [Poster]

 

Kozbial, K; Moser, S; Schwarzer, R; Al Zoairy, R; Stauber, RE; Laferl, H; Maieron, A; Zoller, HM; Beinhardt, S; Staattermayer, A; Stern, R; Steindl-Munda, PE; Strasser, MP; Peck-Radosavljevic, M; Graziadei, I; Trauner, MH; Hofer, H; Ferenci, P Does successful viral eradication translate into beneficial long-term clinical outcome of patients with advanced liver disease due to hepatitis C after DAA therapy?
HEPATOLOGY. 2016; 63(1 SUPP):447A-447A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA. [Poster]
Web of Science

 

Lackner, C; Spindelboeck, W; Rainer, F; Haybaeck, J; Stauber, RE HISTOLOGICAL ACTIVITY AND FIBROSIS PREDICT LONG-TERM SURVIVAL IN PATIENTS WITH COMPENSATED ALCOHOLIC LIVER DISEASE
Journal of Hepatology 2016, Abstract Book. 2016; 64: 229--The International Liver Conference 2016; APR 13-17, 2016; Barcelona, SPAIN. [Poster]

 

Lackner, C; Spindelboeck, W; Rainer, F; Haybaeck, J; Stauber, RE; HISTOLOGICAL ACTIVITY AND FIBROSIS PREDICT LONG-TERM SURVIVAL IN PATIENTS WITH COMPENSATED ALCOHOLIC LIVER DISEASE.
J HEPATOL. 2016; 64: S229-S229.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00212-9 [Poster]
Web of Science FullText FullText_MUG

 

Nagy, BM; Nagaraj, C; Egemnazarov, B; Kwapiszewska, G; Stauber, R; Avian, A; Olschewski, A; Olschewski, H Lack Of Abcg2 Leads To Biventricular Dysfunction And Remodelling In Response To Hypoxia
AM J RESP CRIT CARE. 2016; 193: -International Conference of the American-Thoracic-Society (ATS); MAY 13-18, 2016; San Francisco, CA. [Poster]
Web of Science

 

Niedrist, T; Martini, CV; Renner, W; Posch, U; Schaffellner, S; Stauber, R; Muller, H; Kniepeiss, D Evaluierung des Spender- und Empfänger-PNPLA3 (rs738409) -Polymorphismus bei Lebertransplantation
Austrotransplant 2016. 2016; 29 Suppl. 4: 12-12.-Austrotransplant 2016; OKT 19-21, 2016; Scladming, AUSTRIA. [Poster]

 

Schaffellner, S; Stauber, R; Sereinigg, M; Muller, H; Fickert, P; Hogenauer, C; Krumnikl, J; Lackner, C; Stadlbauer, V; Kniepeiss, D THE DOSE MAKES THE POISON: ACUTE LIVER FAILURE AFTER VITAMIN B3 OVERDOSAGE
TRANSPL INT. .. 2016; 29: 11-11. [Poster]
Web of Science

 

Stauber, RE; Haas, J; Wagner, D; Kniepeiss, D; Stadlbauer, V; Ferlitsch, A; Fuhrmann, V; THE ALBICC MODEL: A NEW PROGNOSTIC TOOL FOR PREDICTION OF SHORT-TERM SURVIVAL IN PATIENTS WITH END-STAGE LIVER DISEASE.
J HEPATOL. 2016; 64: S284-S284.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00346-9 [Poster]
Web of Science FullText FullText_MUG

 

Talakic, E; Schaffellner, S; Kniepeiss, D; Müller, H; Stauber, R; Schöllnast, H; Volume CT-perfusion of the liver and spleen: is there a correlation between hepatic venous pressure gradient (HVPG) and perfusion in patients with liver cirrhosis?
European Congress of Radiology , ECR 2016; MARCH 2-6, 2016; Vienna, Austria. 2016. [Oral Communication]
FullText

 

Yang, JD; Mara, K; Harmsen, WS; Therneau, TM; Peck, M; Stauber, R; Degos, F; Blanc, JF; Leroy, V; Trinchet, JC; Duvoux, C; Assenat, E; Klinker, H; Schott, E; Colombo, M; Izzo, F; Marinho, RT; Pascual, S; Coll, S; Pena, AM; Stal, P; Haglund, U; Johnson, P; Evans, J; Meyer, T; Suddle, A; Fenwick, S; Castel, H; Schwartz, M; Gores, GJ; Roberts, LR; VALIDATION OF MESIAH SCORE SYSTEM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
J HEPATOL. JOURNAL OF HEPATOLOGY64: S330-S331. AMSTERDAM: ELSEVIER SCIENCE BV; ( Presented at: EASL International Liver Congress, Barcelona, SPAIN, APR 13-17, 2016)
Web of Science

 

Beinhardt, S; Al Zoairy, R; Freissmuth, C; Kozbial, K; Hametner, S; Stern, R; Stauber, RE; Maieron, A; Staufer, K; Strasser, MP; Zoller, HM; Graziadei, I; Vogel, W; Peck-Radosavljevic, M; Trauner, M; Ferenci, P; Hofer, H Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria
HEPATOLOGY. . 2015; 62: 746A-747A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Beinhardt, S; Freissmuth, C; Al-Zoairy, R; Kozbial, K; Hametner, S; Stern, R; Stauber, R; Maieron, A; Staufer, K; Strasser, M; Zoller, H; Graziadei, I; Vogel, W; Peck-Radosavljevic, M; Trauner, M; Ferenci, P; Hofer, H EFFICACY AND SAFETY OF IFN-FREE ANTIVIRAL THERAPY IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION: REAL-LIFE EXPERIENCE FROM AUSTRIA
J HEPATOL. 2015; 62: S282-S283.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30192-6 [Poster]
Web of Science FullText FullText_MUG

 

Beinhardt, S; Kozbial, K; Schmidt, A; Freissmuth, C; Mandorfer, M; Strassl, R; al Zoairy, R; Stauber, R; Strasser, M; Sunder-Plassmann, G; Trauner, M; Peck-Radosavljevic, M; Vogel, W; Hofer, H; Ferenci, P REAL LIFE EXPERIENCE WITH INTERFERON/RIBAVIRIN-FREE ANTIVIRAL TREATMENT IN RENAL TRANSPLANT RECIPIENTS AND ENDSTAGE RENAL DISEASE-PATIENTS ON DIALYSIS INFECTED WITH HEPATITIS C VIRUS
J HEPATOL. 2015; 62: S667-S667.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31073-4 [Poster]
Web of Science FullText FullText_MUG

 

Beinhardt, S; Mandorfer, M; Payer, BA; Stattermayer, AF; Datz, C; Maieron, A; Huber, F; Dulic-Lakovic, E; Stauber, R; Fischer, G; Gschwantler, M; Ferenci, P; Hofer, H USEFULNESS OF INTERFERON LAMBDA4-, HLA CLASS II-POLYMORPHISM AND KILLER-IMMUNGLOBULIN-LIKE RECEPTOR-2DL3:C1/C1 TO PREDICT SPONTANEOUS CLEARANCE OF ACUTE HEPATITIS C VIRUS INFECTION
J HEPATOL. 2015; 62: S602-S603.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30943-0 [Poster]
Web of Science FullText FullText_MUG

 

Binder, L; Rainer, F; Haybaeck, J; Xu, S; Spindelboeck, W; Wee, A; Stauber, R; Lackner, C MORPHOMETRICAL QUANTIFICATION OF FIBROSIS CORRELATES WITH CLINICAL CIRRHOSIS STAGE AND PREDICTS LONG-TERM SURVIVAL IN PATIENTS WITH ALCOHOLIC CIRRHOSIS
J HEPATOL. 2015; 62: S758-S758.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31286-1 [Poster]
Web of Science FullText FullText_MUG

 

Horvath, A; Leber, B; Krones, E; Zollner, G; Durchschein, F; Spindelboeck, W; Lemesch, S; Douschan, P; Fauler, G; Stojakovic, T; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V SERUM BILE ACIDS IN CIRRHOSIS DEPEND ON AETIOLOGY.
J HEPATOL. 2015; 62(S2):S344-S344.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30336-6 [Poster]
Web of Science FullText FullText_MUG

 

Horvath, A; Leber, B; Krones, E; Zollner, G; Fickert, P; Stauber, RE; Lemesch, S; Spindelboeck, W; Durchschein, F; Douschan, P; Stiegler, P; Stojakovic, T; Fauler, G; Stadlbauer, V Serum bile acids in cirrhosis depend on aetiology.
Z Gastroenterol. 2015; 53(5):512-512.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA. [Poster]

 

Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Hartl, A; Lemesch, S; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Spindelboeck, W; Oettl, K; Payerl, D; Stadlbauer, V Probiotic supplementation improves liver function but fails to restore neutrophil phagocytosis in stable cirrhosis. A randomized, double-blind, placebo-controlled study
HEPATOLOGY. . 2015; 62: 1216A-1216A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Kerbert, AJ; Schaapman, J; van der Reijden, J; Alex, A; McCormick, A; van Hoek, B; Arroyo, V; Gines, P; Jalan, R; Vargas, V; Stauber, RE; Verspaget, HW; Coenraad, M Impact of genetic variation of the AVP1a receptor on the presence of circulatory failure in patients with acute decompensation of liver cirrhosis or acute-on-chronic liver failure
HEPATOLOGY. . 2015; 62: 1217A-1217A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Kozbial, K; Freissmuth, C; Strassl, R; Al-Zoairy, R; Maieron, A; Stauber, R; Gschwantler, M; Strasser, M; Laferl, H; Bamberger, T; Moser, S; Eder, M; Beinhardt, S; Staettermayer, AF; Mandorfer, M; Ferlitsch, A; Zoller, H; Knoflach, P; Staufer, K; Peck-Radosavljevic, M; Munda, P; Vogel, W; Ferenci, P; Hofer, H VIRAL KINETICS DURING INTERFERON-FREE SOFOSBUVIR CONTAINING TREATMENT REGIMENS IN A REAL-LIFE COHORT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE
J HEPATOL. 2015; 62: S625-S625.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30986-7 [Poster]
Web of Science FullText FullText_MUG

 

Lackner, C; Binder, L; Rainer, F; Stauber, RE MORPHOMETRICAL QUANTIFICATION OF FIBROSIS CORRELATES WITH CLINICAL CIRRHOSIS STAGE AND PREDICTS LONG-TERM SURVIVAL IN PATIENTS WITH ALCOHOLIC LIVER DISEASE
ALCOHOL ALCOHOLISM. 2015; 50: -ESBRA 2015 meeting; SEP 12-15, 2015; Valencia, Spanien. [Oral Communication]
Web of Science

 

Lemesch, S; Spindelböck, W; Leber, B; Payerl, D; Stauber, R; Öttl, K; Stadlbauer, V; Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF
48. Jahrestagung. 2015; -ÖGGH; 19-20 Jun, 2015; Salzburg. [Poster]

 

Lemesch, S; Spindelboeck, W; Leber, B; Payerl, D; Stauber, R; Oettl, K; Stadlbauer, V; Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF.
Z Gastroenterol. 2015; 53(05):77-77.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA. [Poster]
FullText

 

Stauber, R; Stadlbauer, V; Spindelboeck, W; Rainer, F; Posch, A; Streit, A; Jakoby, E; Kniepeiss, D; Muller, H INTERFERON-FREE ANTI-HCV THERAPY AFTER ORGAN TRANSPLANTATION
TRANSPL INT. 2015; 28: 11-11. [Oral Communication]
Web of Science

 

Staufer, K; Stauber, R; Theek, C; von Darl, M; Traussnigg, S; Kienbacher, C; Lackner, C; Steindl-Munda, P; Schulz-Knappe, P; Trauner, M MINIMALLY INVASIVE DIAGNOSIS OF NAFLD AND DISCRIMINATION BETWEEN NAFL AND NASH BY AUTOANTIBODY SIGNATURES
J HEPATOL. 2015; 62: S746-S746.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31258-7 [Poster]
Web of Science FullText FullText_MUG

 

Stern, R; Kozbial, K; Freissmuth, C; Hametner, S; Al Zoairy, R; Moser, S; Karpi, A; Laferl, H; Stauber, RE; Zoller, HM; Maieron, A; Vogel, W; Graziadei, I; Gschwantler, M; Hofer, H; Ferenci, P Safety and Efficacy of Interferon/Ribavirin-Free Therapy in Septuagenerians and Octogenerians with Chronic Hepatitis C
HEPATOLOGY. . 2015; 62: 1128A-1129A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, R; Holzer, M; Pasterk, L; Taschler, U; Heinemann, A; Marsche, G Cirrhosis alters HDL metabolism and function
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz. 2015. [Poster]

 

Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G Metrics of HDL functions are markedly impaired in cirrhosis
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015. [Oral Communication]

 

Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Holzer, M; Marsche, G Liver cirrhosis, high–density lipoproteins and anti-inflammatory and endothelial regenerative activities of serum
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

 

Douschan, P; Kovacs, G; Foris, V; Stauber, R; Olschewski, A; Olschewski, H Performance on cardiopulmonary exercise testing in patients with compensated liver cirrhosis
WIEN KLIN WOCHENSCHR. 2014; 126(19-20):684-684.-ÖGP Jahrestagung; Salzburg, Austria. [Poster]
Web of Science

 

Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Fickert, P; Olschewski, H; Stauber, RE CARDIOPULMONARY EXERCISE TESTING IN PATIENTS WITH PORTAL HYPERTENSION AND EARLY STAGE LIVER DISEASE.
Journal of Hepatology. 2014; 60(1):236-236.-International Liver Congress / 49th Annual meeting of the European Association for the Study of the Liver ; April 9 - 13, 2014; London, ENGLAND. [Poster]

 

Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Wagner, M; Fickert, P; Olschewski, H; Stauber, RE Cardiopulmonary response to exercise in patients with portal hypertension and early stages of liver cirrhosis.
Z Gastroenterol. 2014; 52 - P66: -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); 12. – 14. Juni, 2014; Villach, AUSTRIA. [Poster]

 

Douschan, P; Kovacs, G; Stauber, RE; Foris, V; Olschewski, A; Olschewski, H Impaired exercise capacity in early stage liver cirrhosis - a prospective cross-sectional study
European Respiratory Journal (ERJ). 2014; 44: -ERS Annual Meeting; 6-10 September 2014; Munich, Germany. [Poster]

 

Ganten, TM; Stauber, R; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Gohler, T; Bernard, I; Gerken, G Final analysis of overall survival per subgroups of HCC patients in the prospective, non-interventional INSIGHT study treated with sorafenib
ONCOL RES TREAT. 2014; 37: 123-123. [Poster]
Web of Science

 

Horvath, A; Leber, B; Lemesch, S; Spindelboeck, W; Stauber, RE; Stiegler, P; Stadlbauer, V; Chronic Hepatitis C infection diminishes neutrophil function
Z Gastroenterol 2014; 52 - P73. 2014; -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 12-14, 2014; Villach, Austria. [Poster]

 

Horvath, A; Leber, B; Lemesch, S; Stiegler, P; Stauber, RE; Fickert, P; Zollner, G; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Stadlbauer, V Neutrophil dysfunction in liver cirrhosis despite sufficient opsonisation
Z Gastroenterol 2014; 52 - P62. 2014; -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 12-14, 2014; Villach, Austria. [Poster]

 

Horvath, A; Leber, B; Lemesch, S; Suppan, O; Yuksel, O; Sherzay, K; Zettel, G; Tawdrous, M; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V LISTING FOR LIVER TRANSPLANT: NO IMPACT ON THE QUALITY OF LIFE
TRANSPL INT. 2014; 27: 20-21. [Poster]
Web of Science

 

Horvath, A; Leber, B; Spidelboeck,W; Stiegler, P; Stauber, RE; Lemesch, S; Douschan, P; Durchschein,F; Fickert, P; Krones, E; Zollner, G; Stadlbauer, V THE NEUTROPHIL CAUGHT BETWEEN CIRRHOSIS, GUT PERMEABILITY AND VIRAL HEPATITIS C.
UEG Journal; October 2014; 2 (1 suppl) 22nd United European Gastroenterology Week Vienna, Austria, October 18-22, 2014 Abstract Issue. 2014; -United European Gastroenterology Week; OCT 18-22, 2014; Vienna, Austria. [Poster]

 

Horvath, A; Leber, B; Spindelböck, W; Stiegler, P; Stauber, RE; Lemesch, S; Douschan, P; Durchschein, F; Fickert, P; Krones, E; Zollner, G; Stadlbauer V; THE NEUTROPHIL CAUGHT BETWEEN CIRRHOSIS, GUT PERMEABILITY AND VIRAL HEPATITIS C.
ZMF 10th Anniversary; JUL 17-18, 2014; Graz, Austria. 2014. [Oral Communication]

 

Kozbial, K; Strassl, RP; Al Zoairy, R; Maieron, A; Stauber, RE; Strasser, MP; Laferl, H; Bamberger, T; Staettermayer, A; Zoller, HM; Knoflach, P; Staufer, K; Peck-Radosavljevic, M; Steindl-Munda, PE; Vogel, W; Ferenci, P; Hofer, H Early Viral Kinetics during Interferon-free Sofosbuvir containing Treatment Regimen in a Real-life Cohort of Chronic Hepatitis C Patients
HEPATOLOGY. 2014; 60: 701A-702A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

Leber, B; Horvath, A; Lemesch, S; Spindelboeck, W; Stiegler, P; Stauber, RE; Stadlbauer, V Triple Therapy for chronic Hepatitis C infection: the neutrophil is not amused.
Z Gastroenterol 2014; 52 - V03. 2014; -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 12-14, 2014; Villach, AUSTRIA. [Oral Communication]

 

Nelson, DR; Reddy, KR; Di Bisceglie, AM; Ferenci, P; Crawford, DH; Stauber, RE; Yakovlev, AA; de Ledinghen, V; Hinrichsen, H; Bernstein, DE; de Knegt, RJ; Hassanein, T; Norris, S; Xiong, JYJ; McGovern, BH; Agarwal, K ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients with History of Depression or Bipolar Disorder: Pooled Analysis of Efficacy and Safety in Phase 3 Trials
HEPATOLOGY. 2014; 60: 1159A-1160A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

Öttl, K; Lamprecht, M; Stauber,RE The redox state of human serum albumin as a biomarker
The 14th ISANH Conference on Oxidative Stress, Redox Homeostasis and Antioxidants; JUN, 12-13, 2014; Paris, FRANCE. 2014. [Poster]

 

Stattermayer, A; Zoller, HM; Weiss, KH; Szalay, F; Bruha, R; Houwen, R; Stauber, RE; Steindl-Munda, PE; Hofer, H; Stremmel, W; Ferenci, P Patients with Wilson disease without detectable ATP7B mutations
HEPATOLOGY. 2014; 60: 428A-428A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

Stauber, R; Stadlbauer, V; Spindelboeck, W; Posch, A; Streit, A; Kniepeiss, D; Iberer, F FIRST EXPERIENCES WITH SOFOSBUVIR-BASED INTERFERON FREE TREATMENT OF HCV-INFECTION BEFORE OR AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2014; 27: 15-15. [Oral Communication]
Web of Science

 

Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
2nd Retreat, Doctoral College-Molecular Fundamentals of Inflammation; OKT 29-30, 2014; Seggau, AUSTRIA. 2014. [Poster]

 

Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
Doctoral Day; DEC 10, 2014; Graz, AUSTRIA. 2014. [Poster]

 

A, Horvath; B, Leber; S, Lemesch; P, Stiegler; R, Stauber; P, Fickert; G, Zollner; W, Spindelboeck; E, Krones; F, Durchschein; P, Douschan; V, Stadlbauer INCREASED GUT PERMEABILITY, ELEVATED ENDOTOXIN RELATED PROTEINS AND NEUTROPHIL DYSFUNCTION IN LIVER CIRRHOSIS.
Journal of Hepatology. 2013; 58(S1):S104--48th Annual meeting of the European Association for the Study of the Liver ; 24 April 2013 - 28 April 2013; Amsterdam. Doi: 10.1016/S0168-8278(13)60246-9 [Poster]
Web of Science FullText FullText_MUG

 

Baranyi, A; Meinitzer, A; Stepan, A; Putz-Bankuti, C; Stauber, R; Kapfhammer, HP; Rothenhausler, HB A BIOPSYCHOSOCIAL MODEL OF INTERFERON-alpha-INDUCED DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
EUR PSYCHIAT. 2013; 28: [Poster]
Web of Science

 

Beinhardt, S; Payer, BA; Datz, C; Strasser, M; Maieron, A; Dorn, L; Huber, F; Dulic-Lakovic, E; Stauber, R; Laferl, H; Aberle, JH; Holzmann, H; Krall, C; Vogel, W; Ferenci, P; Hofer, H A DIAGNOSTIC SCORE FOR THE PREDICTION OF SPONTANEOUS RESOLUTION OF ACUTE HEPATITIS C VIRUS INFECTION
J HEPATOL. . 2013; 58: S181-S181.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Beinhardt, S; Payer, BA; Datz, C; Strasser, M; Maieron, A; Dorn, L; Huber, F; Dulic-Lakovic, E; Stauber, R; Laferl, H; Aberle, JH; Holzmann, H; Vogel, W; Fischer, G; Ferenci, P; Hofer, H KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL3 AND ITS HLA-C LIGANDS DO NOT PREDICT SPONTANEOUS RESOLUTION IN PATIENTS WITH ACUTE HEPATITIS C
J HEPATOL. . 2013; 58: S181-S182.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Durchschein, F; Krones, E; Spindelböck, W; Stauber, RE; Lackner, K; Portugaller, H; Stadlbauer-Köllner, V; Fickert, P Resultate der transarteriellen Chemoembolisation (TACE) bei hepatozellulärem Karzinom (HCC) and der Medizinischen Universität Graz zwischen 2004-2011
Zeitschrift für Gastroenterologie. 2013; 51(05):A8-A8.-ÖGGH Jahrestagung 2013; Jun 13-15, 2013; Graz, AUSTRIA. [Poster]

 

Horvath, A; Leber, B; Lemesch, S; Stiegler, P; Stauber, R; Fickert, P; Zollner, G; Spindelböck, W; Krones, E; Durchschein, F; Douschan, P; Stadlbauer-Köllner, V Increased gut permeability, elevated endotoxin related products and neutrophil dysfunction in liver cirrhosis
Z Gastroenterol 2013; 51 - A60. 2013; 51: A60--46. Jahrestagung und 24. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); Jun 13-15, 2013; Graz. [Oral Communication]
FullText

 

Koschny, R; Schott, E; Galle, PR; Gohler, T; Malfertheiner, P; Stauber, R; Buder, R; Bernard, I; Gerken, G Overall survival of specific HCC patient subgroups in prospective, non-interventional INSIGHT study treated with sorafenib
EUR J CANCER. 2013; 49: S623-S623.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Lackner, C; Spindelboeck, W; Haybaeck, J; Terracciano, L; Matejka, J; Douschan, P; Stauber, R A CLINICAL-BIOCHEMICAL-HISTOLOGICAL (CBH) MODEL IMPROVES LONG-TERM MORTALITY PREDICTION IN MALE AND FEMALE PATIENTS WITH ALCOHOLIC LIVER DISEASE
J HEPATOL. . 2013; 58: S220-S220.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60540-1 [Poster]
Web of Science FullText FullText_MUG

 

Lackner, C; Spindelboeck, W; Haybaeck, J; Terracciano, L; Matejka, J; Douschan, P; Stauber, R; IS THERE A ROLE FOR HISTOLOGY IN THE PREDICTION OF LONG-TERMMORTALITY IN ALD?.
ALCOHOL ALCOHOLISM. . 2013; 48: 9-9. [Poster]
Web of Science

 

Leber, B; Tripolt, N; Horvath, A; Lemesch, S; Stojakovic, T; Fauler, G; Stauber, R; Fickert, P; Sourji, H; Stadlbauer-Köllner, V Gut permeability and serum bile acids in metabolic syndrome
Z Gastroenterol 2013; 51 - A59. 2013; 51(5):A59-501.-46. Jahrestagung und 24. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 13-15, 2013; Graz, AUSTRIA. [Poster]
FullText

 

Leber, B; Tripolt, N; Lemesch, S; Horvath, A; Stojakovic, T; Fauler, G; Stauber, R; Fickert, P; Sourij, H; Stadlbauer, V INCREASED GUT PERMEABILITY IN METABOLIC SYNDROME IS NOT ASSOCIATED WITH CHANGES IN BILE ACID PROFILE.
J HEPATOL. 2013; 58(S1):S549-S550.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS. Doi: 10.1016/S0168-8278(13)61366-5 [Poster]
Web of Science FullText FullText_MUG

 

Masser, T; Krones, E; Högenauer, C; Wenzl, HH; Stauber, R; Putz-Bankuti, C; Fickert, P; Zollner, G; Durchschein, F; Stadlbauer-Köllner, V; Spindelböck, W; Petritsch, P; Kump, P Appendektomie und klinischer Verlauf bei Patienten mit Colitis ulcerosa
ÖGGH Jahrestagung; JUN 13-15, 2013; Graz, AUSTRIA. 2013. [Poster]

 

Nguyen-Tat, M; Ganten, TM; Schott, E; Gohler, T; Malfertheiner, P; Stauber, R; Buder, R; Bernard, I; Gerken, G Overall survival of specific HCC patients subgroups in prospective, non-interventional INSIGHT study treated with sorafenib
ONKOLOGIE. 2013; 36: 121-122. [Poster]
Web of Science

 

Pavesi, M; Jalan, R; Amoros, A; Moreau, R; Gines, P; Durand, F; Angeli, P; Caraceni, P; Rodriguez, E; Agarwarl, B; Hopf, C; Alessandria, C; Solis-Munoz, P; Laleman, W; Trebicka, J; Saliba, F; Zeuzem, S; Albillos, A; Gustot, T; Mookerjee, R; Elkrief, L; Benten, D; Montero, JL; Catalina, MV; Concepcion, M; Cordoba, J; McCormick, A; Stauber, R; Vogel, W; De Gottardi, A; Peck-Radosavljevic, M; van Vlierberghe, H; Sperl, J; Groenbaek, H; Mortensen, C; Coenraad, MJ; Morando, F; Domenicali, M; Gerbes, A; Risso, A; Garcia, E; Deulofeu, C; Bernardi, M; Arroyo, V THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF)
J HEPATOL. . 2013; 58: S568-S569.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)61413-0 [Poster]
Web of Science FullText FullText_MUG

 

Rutter, K; Ferlitsch, A; Maieron, A; Stattermayer, AF; Graziadei, I; Dulic, M; Gschwantler, M; Stauber, R; Hofer, H; Peck-Radosavljevic, M; Vogel, W; Trauner, M; Ferenci, P SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
J HEPATOL. . 2013; 58: S30-S30.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60067-7 [Poster]
Web of Science FullText FullText_MUG

 

Scherzer, TM; Laferl, H; Maieron, A; Schwarzer, R; Strasser, M; Stauber, R; Datz, C; Staettermayer, AF; Beinhardt, S; Rutter, K; Trattner, H; Hofer, H; Munda, P; Ferenci, P INFLUENCE OF GENDER, AGE AND ITPA POLYMORPHISM (rs6051702, rs1127354, rs7270101) ON THROMBOCYTOPENIA IN HCV GENOTYPE 1 AND 4 PATIENTS ON ANTIVIRAL THERAPY
J HEPATOL. . 2013; 58: S370-S370.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60901-0 [Poster]
Web of Science FullText FullText_MUG

 

Stauber, RE; Spindelböck, W; Putz-Bankuti, C; Pock, H; Stojakovic, T; Obermayer-Pietsch, B Enhanced Liver Fibrosis (ELF) score is related to liver dysfunction and predicts mortality in cirrhosis.
Z Gastroenterol . 2013; 51(5):501-501.-46. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 13-15, 2013; Graz, AUSTRIA. [Oral Communication]

 

Stauber, RE; Spindelboeck, W; Putz-Bankuti, C; Pock, H; Stojakovic, T; Obermayer-Pietsch, B ENHANCED LIVER FIBROSIS (ELF) SCORE IS RELATED TO LIVER DYSFUNCTION AND PREDICTS MORTALITY IN CIRRHOSIS.
J HEPATOL. 2013; 58(S1):S297-S297.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS. Doi: 10.1016/S0168-8278(13)60734-5 [Poster]
Web of Science FullText FullText_MUG

 

Beinhardt, S; Leiss, W; Graziadei, I; Stauber, RE; Maieron, A; Datz, C; Vogel, W; Ferenci, P Long-term outcome of a large patient cohort with Wilson disease in Austria
HEPATOLOGY. 2012; 56: 827A-827A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

Beinhardt, S; Payer, BA; Datz, C; Strasser, MP; Maieron, A; Dorn, L; Huber, F; Dulic-Lakovic, E; Stauber, RE; Laferl, H; Aberle, JH; Holzmann, H; Krall, C; Vogel, W; Ferenci, P; Hofer, H A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection
HEPATOLOGY. 2012; 56: 677A-678A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

Ganten, T; Schott, E; Galle, P; Gohler, T; Malfertheiner, P; Stauber, R; Buder, R; Achilles, K; Gerken, G; INTERIM ANALYSIS OF OVERALL SURVIVAL PER SUBGROUPS IN THE PROSPECTIVE, NON-INTERVENTIONAL INSIGHT STUDY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB.
ANN ONCOL. 2012; 23: 255-256.-37th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 28-OCT 02, 2012; Vienna, AUSTRIA. [Poster]
Web of Science

 

Jalan, R; Moreau, R; Gines, P; Pavesi, M; Angeli, P; Caraceni, P; Hopf, C; Alessandria, C; Solis-Munoz, P; Laleman, W; Trebicka, J; Saliba, F; Zeuzem, S; Albillos, A; Gustot, T; Baenas, MY; Elkrief, L; Benten, D; Montero, JL; Catalina, MV; Concepcion, M; Cordoba, J; McCormick, A; Stauber, RE; Vogel, W; De Gottardi, A; Peck-Radosavljevic, M; van Vlierberghe, H; Frankova, S; Karlsen, S; Mortensen, CO; Coenraad, M; Morando, F; Gerbes, AL; Risso, A; Garcia, E; Deulofeu, C; Bernardi, M; Arroyo, V Acute-on Chronic Liver Failure (ACLF): A distinct clinical syndrome
HEPATOLOGY. 2012; 56: 249A-249A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Oral Communication]
Web of Science

 

Leber B, Tripolt NJ, Blattl D, Eder M, Wascher, TC, Pieber, TR, Stauber, RE, Sourij, H, Oettl, K, Stadlbauer, V The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: An open label, randomized pilot study
Gut Microbiota in Health and Disease; SEP, 13-15, 2012; Maastricht, THE NETHERLANDS. 2012. [Poster]

 

Malfertheiner, P; Ganten, TM; Schott, E; Galle, PR; Gohler, T; Stauber, R; Buder, R; Achilles, K; Gerken, G; Interim analysis of overall survival per subgroups in the prospective, non-interventional INSIGHT study in patients with hepatocellular carcinoma treated with Sorafenib.
ONKOLOGIE. 2012; 35: 162-162. [Poster]
Web of Science

 

Moreau, R; Gines, P; Jalan, R; Pavesi, M; Durand, F; Angeli, P; Caraceni, P; Pereira, G; Hopf, C; Alessandria, C; Solis, P; Laleman, W; Trebicka, J; Saliba, F; Zeuzem, S; Albillos, A; Gustot, T; Yago, M; Elkrief, L; Benten, D; Montero, JL; Chiva, T; Concepcion, M; Cordoba, J; McCormick, A; Stauber, RE; Vogel, W; De Gottardi, A; Morando, F; Domenicali, M; Gerbes, AL; Risso, A; Garcia, E; Deulofeu, C; Bernardi, M; Arroyo, V DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY
J HEPATOL. 2012; 56: S552-S553.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)61415-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

Putz-Bankuti, C; Pilz, S; Meinitzer, A; März, W; Kienreich, K; Stojakovic, T; Trauner, M; Pieber, TR; Stauber, RE Association of homoarginine and methylarginines with liver dysfunction and mortality in cirrhotic patients.
Z Gastroenterol. 2012; 50(5):517-517.-45. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 14-16, 2012; Wels, AUSTRIA. [Poster]

 

Scherzer, TM; Laferl, H; Maieron, A; Schwarzer, R; Strasser, MP; Stauber, RE; Datz, C; Stattermayer, A; Beinhardt, S; Rutter, K; Steindl-Munda, PE; Hofer, H; Ferenci, P Effect of gender and ITPA polymorphism (rs6051702) on anemia in chronic HCV genotype 1 and 4 patients treated with peg-interferon alpha 2a and ribavirin
HEPATOLOGY. 2012; 56: 1027A-1027A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

Stauber, RE; Spindelböck, W; Putz-Bankuti, C; Pock, H; Stojakovic, T; Obermayer-Pietsch, B The ELF test – a new prognostic marker in cirrhosis.
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):571-572.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 20-22, 2012; Graz, AUSTRIA. [Poster]
Web of Science

 

Stauber, RE; Spindelboeck, W; Birner-Gruenberger, R; Putz-Bankuti, C; Stadlbauer, V; Lackner, C; Oettl, K Human nonmercaptalbumin-2 (HNA2): a novel prognostic marker in chronic liver failure
HEPATOLOGY. 2012; 56: 975A-975A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

Valentin, T; Putz-Bankuti, C; Leitner, E; Talakic, E; Schoellnast, H; Fickert, P; Krejs, GJ; Kessler, HH; Stauber, RE Pleuro-pulmonary nocardiosis as opportunistic infection in a patient with chronic hepatitis C under combination treatment with pegylated interferon, ribavirin and boceprevir
http://www.oeginfekt.at/download/6-oeik_programm_2012.pdf. 2012; -6. Österreichischer Infektionskongress; APR 18-21, 2012; Saalfelden, AUSTRIA. [Poster]

 

Amrein, K; Worm, H; Otto, R; Smolle, KH; Ribitsch, W; Stauber, R Rapid reversal of hypoglycaemic coma despite profound metabolic acidosis
Abstractband Ernährung 20112011; -Ernährung 2011; MAY 26-28, 2011; Graz, AUSTRIA. [Poster]

 

Amrein, K; Worm, H; Otto, R; Smolle, KH; Ribitsch, W; Stauber, R SEVERE METABOLIC ACIDOSIS REVERSED BY THIAMINE WITHIN 24 HOURS
Intensivmedizin und Notfallmedizin. 2011; 48(4):-Jahrestagung der DGIIN und ÖGIAIM; JUN 15-18, 2011; Vienna, AUSTRIA. [Poster]

 

Baranyi, A; Meinitzer, A; Stepan, A; Matejka, J; Stauber, R; Rothenhäusler, HB Biopsychosoziale Auswirkungen von Interferon-Alpha auf Patienten mit chronischer Hepatitis C.
Hauptprogramm ÖGPP2011; 26-26.-11. Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie; APR 27-30, 2011; Gmunden, AUSTRIA. [Poster]

 

Baranyi, A; Meinitzer, A; Stepan, A; Matejka, J; Stauber, R; Rothenhäusler, HB Biopsychosocial consequences of Interferon-alpha (IFN-alpha) therapy in patients with chronic hepatitis C infection.
European Psychiatry2011; 26, Suppl.1: P02-12--19th European Congress of Psychiatry; March 12-15, 2011; Vienna, AUSTRIA. [Poster]

 

Ganten, TM; Schott, E; Gohler, T; Wiest, R; Malfertheiner, P; Stauber, R; Buder, R; Achilles, K; Gerken, G First interim results from a non-interventional study in hepatocellular carcinoma patients treated with sorafenib - the INSIGHT study
ONKOLOGIE. 2011; 34: 215-215. [Oral Communication]
Web of Science

 

Gruber-Wackernagel, A; Rinner, B; Griesbacher, A; Groselj-Strele A; Hofer, A; Legat, FJ; Stauber, R; Byrne, SN; Wolf, P Phototherapeutic hardening modulates systemic baseline cytokine levels in PLE patients
Journal of Investigative Dermatology. 2011; 131(2):S105-S105.-41st Annual ESDR Meeting; SEP 7-9; 2011; Barcelona, Spain. [Poster]
Web of Science

 

Mészáros, K; Zirngast, B; Wagner, D; Stauber, R; Mächler, H; Müller, H; Iberer, F; RIenmüller, R; Tscheliessnigg, KH Evaluierung für LTX endete in Lebersanierung durch Peri/Epikardektomie
Eur Surg Vol 43 Supplement 241. 2011; 29-29.-52. Österreichischer Chirurgenkongress; JUn 23 - 25,2011; Vienna, AUSTRIA. [Oral Communication]

 

Pinter, M; Hucke, F; Graziadei, I; Maieron, A; Konigsberg, R; Stauber, RE; Gruenberger, B; Muller, C; Koelblinger, C; Peck-Radosavljevic, M; Sieghart, W TRANSARTERIAL (CHEMO-)EMBOLIZATION VERSUS SORAFENIB IN PATIENTS WITH ADVANCED STAGE HEPATOCELLULAR CARCINOMA
HEPATOLOGY. 2011; 54: 1388A-1388A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA. [Poster]
Web of Science

 

Putz-Bankuti, C; Kessler, HH; Schilcher, G; Schneditz, D; Konrad, PM; Rosenkranz, AR; Stauber, RE “Negative HCV Clearance” während der extrakorporalen Nierenersatztherapie bei Patienten mit terminaler Niereninsuffizienz und chronischer HCV Infektion
14. Interdisziplinäres Gastroenterologisch-Hepatologisches Wintertreffen; MAR 19-26, 2011; Galtür, AUSTRIA. 2011. [Oral Communication]
FullText

 

Ribitsch, W; Putz-Bankuti, C; Stauber,RE; Schilcher,G; Quehenberger,F; Stojakovic,T; Rosenkranz, AR;Horina,J; Evaluation of neutrophil gelatinase-associated lipocalin as prognostic tumor marker in hepatocellular cancer
Mitteilungen der Deutschen Gesellschaft für Nephrologie Heft 3/2011,S. 46 ff.. 2011; -3.Jahrestagung der Deutschen Gesellschaft für Nephrologie; SEP 10-13,2011; Berlin, Germany. [Poster]

 

Scherzer, TM; Stauber, R; Staettermayer, AF; Zinober, K; Maieron, A; Strasser, M; Laferl, H; Rutter, K; Beinhardt, S; Datz, C; Steindl-Munda, P; Hofer, H; Ferenci, P EFFECTS OF SNP RS6051702 POLYMORPHISM ON ANEMIA AND TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS
J HEPATOL. 2011; 54: S192-S193.-46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)60473-X [Poster]
Web of Science FullText FullText_MUG

 

Schilcher, G; Putz-Bankuti, C; Schneditz, D; Kessler, H; Rosenkranz, AR; Stauber, RE Increase of HCV RNA levels during hemodialysis treatment in patients with chronic hepatitis C.
http://www.asn-online.org/education_and_meetings/kidneyweek/archives/. 2011; -American Society of Nephrology (ASN), Annual Meeting 2011; NOV 10-13, 2011; Philadelphia, USA.
FullText

 

Schilcher, G; Putz-Bankuti, C; Schneditz, D; Konrad, PM; Rosenkranz, AR; Kessler, HH; Stauber, RE Increase of HCV RNA levels during hemodialysis treatment in patients with chronic hepatitis C.
Abstractband, ÖGN 2011. 2011; -Jahrestagung der Österreichischen Gesellschaft für Nephrologie (ÖGN); NOV 4-5, 2011; Gmunden, AUSTRIA. [Oral Communication]

 

Schilcher, G; Putz-Bankuti, C; Schneditz, D; Konrad, PM; Rosenkranz, AR; Kessler, Stauber, RE Increase of HCV RNA levels during hemodialysis treatment in patients with chronic hepatitis C
Abstractband der 3. Jahrestagung der DGfN. 2011; -3. Jahrestagung der Deutschen Gesellschaft für Nephrologie; SEP 10-13, 2011; Berlin, GERMANY. [Poster]

 

Sieghart, W; Pinter, M; Graziadei, I; Hucke, F; Rasoul-Rockenschaub, S; Stauber, R; Wagner, D; Vogel, W; Peck-Radosavljevic, M OUTCOME OF PATIENTS WITH CHILD-PUGH C LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
J HEPATOL. 2011; 54: S265-S265.-46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)60658-2 [Poster]
Web of Science FullText FullText_MUG

 

Stauber, RE; Scherzer, T; Putz-Bankuti, C; Matejka, J; Spindelboeck, W; Zinober, K; Bernhardt, S; Wehr, E; Stojakovic, T; Kessler, HH; Ferenci, P; Obermayer-Pietsch, B BASELINE VITAMIN D LEVELS DO NOT INFLUENCE SVR IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 INFECTION UNDERGOING PEGINTERFERON/RIBAVIRIN TREATMENT.
J HEPATOL. 2011; 54: S468-S469.-46th Annual Meeting of the European Association for the Study of the Liver (EASL); MAR 30-APR 3, 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)61188-4 [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE Alpha-fetoprotein and des-gamma-carboxy prothrombin as serum markers for hepatocellular carcinoma.
Clin Chem Lab Med 2011; 49: S275-S275.-IFCC WorldLab and EuroMedLab; MAY 15-19, 2011; Berlin, GERMANY. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE Evaluation of specific tumor markers for hepatocellular carcinoma.
Clin Chem Lab Med. 2011; 49(10):A25-A26.-Annual Assembly of the Swiss Society of Clinical Chemistry & Tri-National Congress of Laboratory Medicine; NOV 2-4, 2011; Zurich, SWITZERLAND. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Pock, H; Stauber, RE EVALUATION OF FOUR DIFFERENT TUMOR MARKERS FOR HEPATOCELLULAR CARCINOMA
J HEPATOL. 2011; 54: S401-S401. [Poster]
Web of Science

 

Weiss, KH; Schots, M; Gotthardt, DN; Ferenci-Foerster, D; Maieron, A; Stauber, R; Reuner, U; Houwen, RHJ; Stremmel, W; Ferenci, P EFFICACY AND SAFETY OF D-PENICILLAMINE AND TRIENTINE FOR THE TREATMENT OF WILSON DISEASE
J HEPATOL. 2011; 54: S1-S1. Doi: 10.1016/S0168-8278(11)00096-1 [Oral Communication]
Web of Science FullText FullText_MUG

 

Baranyi, A; Meinitzer, A; Stepan, A; Matejka, J; Stauber, R; Rothenhäusler, HB Biopsychosoziale Auswirkungen von Interferon-alpha auf Patienten mit chronischer Hepatitis C.
Abstracts 2010 DGPPN2010; P(011):004--Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde - Annual Congress of the German Association for Psychiatry and Psychotherapy (DGPPN); NOV 24-27, 2010; Berlin, GERMANY. [Poster]

 

Gries, A; Putz-Bankuti, C; Haditsch, B; Stojakovic, T; Stauber RE Beta2-Glycoprotein-I and Autoantibodies in Liver Cirrhosis
7th International Congress on Autoimmunity; MAY 5-9, 2010; Ljubljana, Slovenia. 2010. [Poster]
FullText

 

Gutschi, T; Heidler, S; Pachernegg, O; Lackner, C; Stauber, R; Hutterer, G; Pummer, K; Zigeuner, R; Detektion zirkulierender Tumorzellen bei Patienten mit Nierenzellkarzinom.
J UROL UROGYNÄKOL 2010; 17 (Sonderheft 3)201s; -36. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der österreichischen Gesellschaft für Urologie und Andrologie; Jun 9-12, 2010; Munich, Germany. [Oral Communication]

 

Gutschi, T; Pachernegg, O; Lackner, K; Hutterer, GC; Stauber, R; Pummer, K; Zigeuner, R Detection of circulating tumor cells in patients with renal cell carcinoma compared with a control group.
J Clin Oncol2010; 28(15s):4618-4618.-2010 ASCO Annual Meeting; JUN 4-8, 2010; Chicago, IL., USA. [Poster]

 

Gutschi, T; Zigeuner, R; Heidler, S; Pachernegg, O; Lackner, K; Hutterer, GC; Stauber, R; Pummer, K; Lackner, K Detection of circulating tumor cells in patients with renal cell carcinoma compared with a control group
EUR UROL SUPPL2010; 9(6):-EAU 10th Central European Meeting; OKT 22-23, 2010; Bratislava,SLOVAKIA. [Poster]

 

Inzinger, M; Tilz, H; Ginter-Hanselmayer, G; Stauber, R; Hödl, S; Weger, W Laugier-Hunziger syndrome: a rare cause of longitudinal melanonychia.
Abstractband, 1st International Summit for Nail Diseases 2010; 110-111.-1st Inetrnational Summit for Nail Diseases; JUL 2-4, 2010; Athens, GREECE. [Poster]

 

Putz-Bankuti, C; Stojakovic, T; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, R Reduction of serum leptin levels during antiviral treatment with peginterferon and ribavirin in patients with chronic hepatitis C
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A10-A10.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 29-OCT 2; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Scherzer, TM; Stattermayer, A; Kessler, HH; Gschwantler, M; Strasser, MP; Laferl, H; Maieron, A; Stauber, RE; Datz, C; Rutter, K; Beinhardt, S; Steindl-Munda, PE; Hofer, H; Ferenci, P IMPACT OF IL28B POLYMORPHISM ON TREATMENT DURATION IN HCV GENOTYPE 1 AND 4 PATIENTS
HEPATOLOGY. 2010; 52(4): 923
Web of Science

 

Scherzer, TM; Stauber, RE; Maieron, A; Laferl, H; Gschwantler, M; Beinhardt, S; Rutter, K; Stattermayer, A; Steindl-Munda, PE; Hofer, H; Ferenci, P UNDETECTABLE HCV RNA AFTER SILIBININ IV TREATMENT IS ASSOCIATED WITH HIGH ON TREATMENT RESPONSE RATES IN HCV NULLRESPONDERS
HEPATOLOGY. 2010; 52(4):835- [Poster]
Web of Science

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)61118-X [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. 2010. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum adipokine levels and lipoproteins in patients with chronic hepatitis C.
Clin Chem Lab Med 2010; 48(10):A211-A211.-3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum adipokine levels and lipoproteins in patients with chronic hepatitis C.
40. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2010; Maikammer, GERMANY. 2010. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE EFFECTS OF ANTIVIRAL TREATMENT ON SERUM LEPTIN LEVELS AND LIPID PROFILE IN PATIENTS WITH CHRONIC HEPATITIS C
ATHEROSCLER SUPPL. 2010; 11(2): MS456-78th Congress of the European Atherosclerosis Society; JUN 20-23, 2010; Hamburg, GERMANY. Doi: 10.1016/S1567-5688(10)70957-0
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum leptin levels and lipid profile in patients with chronic C.
17. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 7-8, 2010; St. Gilgen, AUSTRIA. 2010. [Oral Communication]

 

Gries, A; Putz-Bankuti, C; Haditsch, B; Stauber, RE Evidence that Beta2-glycoprotein I is synthetized by the liver.
Zentrumsmeeting, Zentrum für Physiologische Medizin; JUL 8; Graz, AUSTRIA. 2009. [Poster]

 

Jung, A; Krisper, P; Zadora, M; Haditsch, B; Stauber, R; Holzer, H; Schneditz, D Clearance and rate of conjugated bilirubin removal during extracorporeal liver support therapy with FPSA PrometheusTM.
IFMBE Proceedings2009; 25(VII):620-624.-World Congress on Medical Physics and Biomedical Engineering; SEP 7-12, 2009; Munich, GERMANY. (ISBN: 978-3-642-03897-6 ) [Oral Communication]
FullText

 

Maier, R; Kovacs, G; Stauber, R; Brodmann, M; Fruhwald, FM; Aberer, E; Gruenig, E; Olschewski, H Exercise Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
Eur J Heart Fail 2009; 8(2):1524-1524.- Heart Failure 2009; MAY 30 - JUN 2, 2009; Nice, FRANCE. [Poster]

 

Maieron, A; Metz-Gercek, S; Scherzer, TM; Laferl, H; Fischer, G; Bischof, M; Steindl-Munda, PE; Stauber, RE; Ziachehabi, A; Hofer, H; Gschwantler, M; Vogel, W; Ferenci, P SHORTENING OF TREATMENT DURATION IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 2 AND 3-IMPACT OF RIBAVIRIN DOSE - RESULTS OF A RANDOMIZED MULTICENTRE TRIAL
HEPATOLOGY. 2009; 50(4):1578- [Poster]
Web of Science

 

Oettl, K; Brtnik, M; Payerl, D; Stadlbauer, V; Stauber, RE Oxidative modification and high levels of bilirubin impair binding properties of albumin in Advanced Liver Disease
FREE RADICAL RES. 2009; 43: 43-43.-SFRR-Europe Meeting 2009; AUG 26-29, 2009; Rome, ITALY. [Oral Communication]
Web of Science

 

Oettl, K; Greilberger, J; Lamprecht, M; Stadlbauer, V; Stauber, RE; Frank, S; Marsche, G Oxidative Modified Human Serum Albumin: New Aspects of a well Known Molecule.
Pteridines. 2009; 20: 28-29.-International Winter-Workshop on Clinical, Chemical and Biochemical Aspects of Pteridines; MAR 1-8, 2009; St.Christoph, AUSTRIA. [Oral Communication]

 

Putz-Bankuti, C; Stojakovic, T; Steidl, K; Scharnagl, H; Stauber, RE Turbidimetrische Messung der Hyaluronsäure im Serum bei Patienten mit Leberzirrhose.
Z Gastroenterol 2009; 47: 495-495.-42. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH) und 50. Österreichischer Chirurgenkongress; JUN 18-20, 2009; Vienna, AUSTRIA. [Poster]

 

Rybczynski, M; Leber, B; Smolle, KH; Stauber, R; Stadlbauer, V Innate immune dysfunction in sepsis and acute-on-chronic liver failure
WIEN KLIN WOCHENSCHR. 2009; 121(1-2):A9-A9.-Wiener Intensivmedizinische Tage; FEB 11-14, 2009; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Scherzer, TM; Beinhardt, S; Rutter, K; Stattermayer, A; Maieron, A; Stauber, R; Gschwantler, M; Steindl-Munda, P; Hofer, H; Ferenci, P Silibinin as the treatment of chronic hepatitis C with peginterferon/ribavirin non-responders - The search for optimal therapy schemes
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A25-A26. [Poster]
Web of Science

 

Scherzer, TM; Beinhardt, S; Rutter, K; Stattermayer, A; Maieron, A; Stauber, RE; Gschwantler, M; Kerschner, H; Steindl-Munda, PE; Hofer, H; Ferenci, P SILIBININ FOR TREATMENT OF NONRESPONDERS TO PEGINTERFERON/RIBAVIRIN - SEARCH FOR THE OPTIMAL DOSING SCHEDULE
HEPATOLOGY. 2009; 50(4):847- [Poster]
Web of Science

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
39. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2009; Maikammer, GERMANY. 2009. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Improvement of lipoprotein pattern and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
1st Styrian Conference on Lipid Mass Spectrometry; OCT 21-22, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Steidl, K; Scharnagl, H; Stauber, RE Turbidimetric assay for measurement of hyaluronic acid in patients with liver cirrhosis.
Clin Chem Lab Med 2009; 47: S294-S294.-18th IFCC - EFCC European Congress of Clinical Chemistry and Laboratory Medicine; JUN 7-11, 2009; Innsbruck, AUSTRIA. [Poster]

 

Duller, D; Haas, J; Stadlbauer, V; Kniepeiss, D; Palma, S; Gurakuqi, G; Gallent, HR; Iberer, E; Stauber, RE The LB model: A new prognostic tool for prediction of short term survival in patients with end stage liver disease
J HEPATOL. 2008; 48: S81-S81.-EASL - Meeting of the European Society for Liver Disease; APR 23-26; Milan, ITALY. Doi: 10.1016/S0168-8278(08)60194-4 [Poster]
Web of Science FullText FullText_MUG

 

Duller, D; Haas J., Stadlbauer V., Palma St., Gallent H., Kniepeiss D., Smolle KH., Stauber RE The LB Model: a New Prognostic Tool for Prediction of Short Term Survival in Patients with End-Stage Liver Disease
Liver Transplantation Supplement of the Meeting of the International Society of Liver Transplantation2008; 14(S1):S201-S202.-ILTS – Meeting of the international liver transplant society 2008; JUL 12-14; Paris, France. [Poster]
Web of Science

 

Ferenci, P; Laferl, H; Scherzer, TM; Gschwantler, M; Maieron, A; Brunner, H; Stauber, RE; Bischol, M; Bauer, B; Datz, C; Loschenberger, K; Formann, E; Hofer, H; Steindl-Munda, PE RESPONSE-GUIDED THERAPY WITH PEGINTERFERON ALFA-2A (40KD) PLUS RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 OR 4: PROSPECTIVE RANDOMIZED STUDY OF EXTENDED THERAPY IN PATIENTS WITHOUT A RAPID VIROLOGICAL RESPONSE
HEPATOLOGY. 2008; 48(4):116--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Oral Communication]
Web of Science

 

Gries, A; Putz-Bankuti, C; Haditsch, B; Stauber, RE; Evidence that Beta2-Glycoprotein-I is synthetized by the liver.
Trilateral Symposium of Physiology in honor of Helmut Hinghofer-Szalkay.; SEPT 18-19, 2008; Graz, AUSTRIA. 2008. [Poster]
FullText

 

Habib, J; Steidl, K; Gulamber, C; Stauber, RE; Kessler, HH; Marth, E; Putz-Bankuti, C Treatment of hepatitis C virus (HCV) infection: response to peginterferon plus ribavirin of HCV genotype 4 infection versus HCV subtype 1b infection.
Clinical Chemistry and Laboratory Medicine2008; 46(4):A57-A57.-Seventh International Symposium on Molecular Diagnostics; May 22-24, 2008; Graz, AUSTRIA. [Poster]

 

Madl, C; Kitzberger, R; Warszawska, J; Holzinger, U; Hammer, J; Stauber, R; Firlinger, F; Lenz, K Effect of intravenous esomeprazole versus ranitidine on gastric pH in critically ill patients - a prospective, randomized, double-blind, multicenter study
WIEN KLIN WOCHENSCHR. 2008; 120(1-2):A8-A8.-WIT 2008; FEB 6-9, 2008; Vienna, AUSTRIA. [Poster]
Web of Science

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Aberer, E; Gruenig, E; Olschewski, H Stress Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
CIRCULATION. 2008; 118(12):E294-E294.- World Congress of Cardiology; MAY 18-21, 2008; Buenos Aires, ARGENTINA. [Poster]
Web of Science

 

Stange, J; Goetze, A; Klammt, S; Strube, S; Gruenert, J; Stauber, R; Emmerich, J; Mitzner, S; Koball, S; Hickstein, H; Liebe, S; Schmidt, RH BED SIDE REDUCTION OF INDUSTRIAL CONSERVATIVE AND VASODILATOR CAPRYLATE FROM ALBUMIN MAY IMPROVE ITS THERAPEUTIC EFFECT ON COMPLICATIONS OF PORTAL HYPERTENSION-A CONTROLLED STUDY
HEPATOLOGY. 2008; 48(4):1697--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; März, W; Wascher, TC; Trauner, M Improvement of dyslipidemia and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
Clin Chem Lab Med. 2008; 46(9):A181-A181.-5. Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 21-24, 2008; Mannheim, GERMANY. [Poster]

 

Ferenci, P; Laferl, H; Scherzer, TM; Brunner, H; Maieron, A; Gschwantler, M; Stauber, RE; Hubmann, R; Staufer, K; Datz, C; Bischof, M; Hofer, H; Loschenberger, K; Steindl-Munda, PE Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin treatment in patients with genotypes 1 or 4
HEPATOLOGY. 2007; 46(4):814A-815A. [Poster]
Web of Science

 

Haditsch, B; Krisper, P; Stauber, R; Mekaroonkamol, P; Holzer, H; Schneditz, D Measurement of indocyanine green concentration and elimination in the extracorporeal circulation during hemodialysis and extracorpotreal liver support therapy.
NEPHROL DIALYSIS TRANSPLANT. 2007; 22: 122-122.-XLIV ERA-EDTA Congress; JUN 21-24, 2007; Barcelona, SPAIN. [Poster]
Web of Science

 

Kovacs, G; Maier, R; Scheidl, S; Hesse, C; Brodmann, M; Stauber, R; Fürst, F; Aberer, E; Salmhofer, W; Thonhofer, R; Grünig, E; Olschewski, H Die Rolle der Stressechokardiographie und der Spiroergometrie in der Früherkennung der pulmonalarteriellen Hypertonie
Pneumologie Update; JUN 8-9; 2007; innsbruck, AUSTRIA. 2007. [Poster]

 

Madl, C; Kitzberger, Z; Warszawska, J; Holzinger, U; Hammer, J; Stauber, R; Firlinger, F; Lenz, K Effect of intravenous esomeprazole versus ranitidine on gastric pH in critically ill patients - A prospective, randomized, double-blind, multicenter study
CRIT CARE MED. 2007; 35(12):A11-A11. [Poster]
Web of Science

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Aberer, E; Gruenig, E; Olschewski, H Stress Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
Echocardiography Today and Tomorrow; JUN 25-29, 2007; St. Wolfgang, AUSTRIA. 2007. [Poster]

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Aberer, E; Gruenig, E; Olschewski, H Stress Doppler echocardiography for screening of patients at risk for pulmonary arterial hypertension.
Eur J Echocardiography 2007; 8(Supp):-EUROECHO 2007; DEC 5-8, 2007; Lisbon, PORTUGAL. [Poster]

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Brodmann, M; Fruhwald, FM; Aberer, E; Gruenig, E; Olschewski, H Exercise Stress Echocardiography for Screening of Patients at Risk for Pulmonary Arterial Hypertension.
J Kardiol 2007; 14(5-6):171-171.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; MAY 30 - JUN 2, 2007; Salzburg, AUSTRIA. [Poster]

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Fruhwald, F; Aberer, E; Gruenig, E; Olschewski, H Screening of patients at risk for pulmonary arterial hypertension: role of exercise stress echocardiography.
Eur Heart J 2007; 28(Supp):183-183.-Congress of the European Society of Cardiology; SEP 1-5, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Maier, R; Kovacs, G; Scheidl, S; Hesse, C; Salmhofer, W; Stauber, R; Fruhwald, FM; Aberer, E; Gruenig, E; Olschewski, H Screening of Patients at Risk for Pulmonary Arterial Hypertension: Role of Exercise Stress Echocardiography.
6th International Pulmonary Hypertension Forum; MAR 10-11, 2007; Basel, SWITZERLAND. 2007. [Poster]

 

Valentin, T; Hinterleitner, T; Högenauer, C; Schreiber, F; Ott, A; Wenzl, H; Stauber, R; Langner, C; Hauser, H; Krejs, GJ; Eherer, A Cronkhite-Canada-Syndrom: Eine seltene Ursache chronischer Diarrhoe mit enteralem Eiweissverlust
Z Gastroenterol 2007. 2007; 44(A24):-40. Jahrestagung der ÖGGH; JUN 14-16, 2007; Innbruck, AUSTRIA. [Poster]

 

Vogel, W; Brunner, H; Maieron, A; Graziadei, I; Rosenbeiger, M; Jilek, K; Stauber, RE; Wolkersdorfer, D Peginterferon alfa-2b and ribavirin treatment of patients with chronic hepatitis C and normal versus elevated aminotransferase levels final results of a prospective open trial
HEPATOLOGY. 2007; 46(4):385A-385A. [Poster]
Web of Science

 

Wedemeyer, H; Tauber, E; Schuller, E; Wiegand, J; Schiefke, I; Hofmann, WP; Zeuzem, S; Hinrichsen, H; Thursz, MR; Jilma, B; Stauber, RE; Manns, MP; Klade, CS Differential pattern of HCV-specific T cell responses distinguishes SVR and relapse patients receiving standard antiviral therapy plus therapeutic IC41 vaccination
HEPATOLOGY. 2007; 46(4):851A-851A. [Poster]
Web of Science

 

Ferenci, P; Brunner, H; Laferl, H; Bergholz, U; Rosenbeiger, M; Stauber, R; Maieron, A; Fischer, G; Bischof, M; Steindl-Munda, P Further reduction of ribavirin dose in HCV genotype 2/3 patients receiving peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)): Interim results of a randomised controlled trial
J HEPATOL. 44: S37-S37.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80083-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

Ferenci, P; Scherzer, T; Laferl, H; Staufer, K; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, R; Datz, C; Bischof, M; Stauber, R; Kessler, H; Steindl-Munda, P High SVR rate, with 24 weeks of peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 patients with a week-4 virological response
J CLIN VIROL. 36: S50-S50. Doi: 10.1016/S1386-6532(06)80153-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

Ferenci, R; Bergholz, U; Laferl, H; Scherzer, TM; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, RR; Datz, C; Bischof, M; Stauber, R; Steindl-Munda, R 24 week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) in HCV genotype 1 or 4 'superresponders'
J HEPATOL. 44: S6-S6.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Graziadei, IW; Nilica, B; Stadlbauer, V; Stauber, R; Trauner, M; Mueller, C; Vogel, W Imatinib treatment for patients with advanced stage hepatocellular carcinoma: A multicenter phase II trial
HEPATOLOGY. 2006; 44(4):503A-504A. [Poster]
Web of Science

 

Oettl, K; Brtnik, M; Puhl, M; Neuhold, S; Payerl, D; Stauber, RE Measurement of the redox state of cysteine-34 in human serum albumin
2 nd International Symposium of the Human Nutrition & Metabolism Research and Training Center; OCT 9-10, 2006; Graz, Austria. 2006. [Poster]

 

Oettl, K; Greilberger, J; Stadlbauer, V; Petter, F; Lackner, C; Putz-Bankuti, C; Stauber, R Redox state of serum albumin and carbonyl content of plasma proteins in advanced liver disease
FREE RADICAL RES. 40: S151-S151.-13 th Biennal Congress, Society for Free Radical Research-International; AUG 15-19, 2006; Davos, Switzerland. [Poster]
Web of Science

 

Oettl, K; Stadlbauer, V; Petter, F; Greilberger, J; Putz-Bankuti, C; Lackner, K; Stauber, R Redox state of human serum albumin in liver disease
FEBS Journal. 273(1):164-164.-31 st FEBS Congress, Molecules in Health and Disease; JUN 24-29, 2006; Istanbul, Turkey. [Poster]
Web of Science

 

Raggam, RB; Santner, BI; Michelin, BDA; Bozic, M; Stelzl, E; Putz-Bankuti, C; Stauber, RE; Wagner, J; Lackner, A; Hafenscherer, R; Marth, E; Kessler, HH Standardized saliva collection and quantification in molecular diagnostics: evaluation of a novel saliva collection system and quantification kit
Clin Chem Lab Med 2006. 44(9):199-213.-First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; Oct 4 - 7, 2006; Salzburg. [Poster]

 

Raggam, RB; Santner, BI; Michelin, BDA; Putz-Bankuti, C; Stauber, RE; Gurakuqi, G; Wagner, J; Marth, E; Kessler, HH HCV and HIV-1 viral load in saliva: evaluation of a standardized saliva quantification kit
Clin Chem Lab Med 2006. CCLM2006; 44(4):1-18.-Sixth International Symposium on Molecular Diagnostics; May 25 - 27, 2006; Graz, Austria. [Oral Communication]

 

Schneditz, D; Bachler, I; Stadlbauer, V; Stauber, R Continuous and non-invasive measurement of circulatory function during paracentesis of tense ascites
Wissenschaftliche Gesellschaft der Ärzte in der Steiermark; Apr 6, 2006; Graz, AUSTRIA. 2006. [Oral Communication]

 

Stauber, RE; Oettl, K; Stadlbauer, V; Greilberger, J; Krisper, P; Lackner, C Redox state of albumin and carbonyl content of proteins are altered in acute-on-chronic liver failure
HEPATOLOGY. 44(4):364A-365A.-57th Annual meeting of the AASLD; OCT 27-31, 2006; Boston, USA. [Poster]
Web of Science

 

Stauber, RE; Stadlbauer, V; Struber, G; Kaufmann, P Evaluation of four prognostic scores in patients with acute-on-chronic liver failure
J HEPATOL. 44: S69-S70.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80166-2 [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Gurakuqi, G; Scharnagl, H; Stadlbauer, V; Stauber, R; Maerz, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and incomplete response to ursodeoxycholic acid.
Clin Chem Lab Med. 44(9):A207-A207.-First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC); OCT 4-7, 2006; Salzburg, Austria. [Poster]

 

Vogel, W; Brunner, H; Rosenbeiger, M; Graziadei, I; Maieron, A; Jilek, K; Stauber, R; Wolkersdorfer, D; Ulmer, H Treatment comparison of patients with chronic hepatitis C and elevated ALT vs patients with persistently normal ALT - Preliminary results of a prospective open trial
J HEPATOL. 44: S228-S228.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80615-X [Poster]
Web of Science FullText FullText_MUG

 

Vogel, W; Brunner, H; Rosenbeiger, M; Graziadei, IW; Maieron, A; Jilek, K; Stauber, R Treatment comparison of chronic hepatitis C patients with normal and elevated transaminses: Viral load is predictive of ETR - Preliminary results of a prospective trial
GASTROENTEROLOGY. 2006; 130(4):A843-A843. [Poster]
Web of Science

 

Ferenci, P; Bergholz, U; Laferl, H; Gurguta, C; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, R; Datz, C; Bischof, M; Stauber, R; Steindl-Munda, P Is shorter treatment with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) possible in HCV genotype 1 'super-responders'? preliminary results of a prospective randomized clinical trial
HEPATOLOGY 2005 42: -.
Web of Science

 

Ferenci, P; Brunner, H; Laferl, H; Czizek, U; Rosenbeiger, M; Stauber, R; Maieron, A; Fischer, G; Steindl-Munda, P Interim analysis of a randomized, controlled study comparing the efficacy of 40KD peg-interferon alfa2a in combination with 800mg or 400 mg ribavirin/day in chronic hepatitis C, genotype 2/3
GASTROENTEROLOGY. 2005; 128(4): A684-A684.
Web of Science

 

Jung, A; Krisper, P; Haditsch, B; Stauber, R; Holzer, H; Schneditz, D Zastosowanie dwu-kompartmentowego modelu do opisu kinetyki bilirubiny trakcie pozaustrojowej terapii watroby.
Materialy konferencyjne XIV Krajowej Konferencji Naukowej Biocybernetyka i Inzynieria Biomedyczna2005; 505-510.-XIV National Scientific Conference of Biocybernetics and Biomedical Engineering; SEP 21-23, 2005; Czestochowa, POLAND. [Oral Communication]

 

Jung, A; Krisper, P; Haditsch, B; Stauber, R; Holzer, H; Schneditz, D Contribution of high flux dialysis to bilirubin removal in extracorporeal liver support therapy.
The International Journal of Artificial Organs2005; 28(9):933-933.-XXXII Annual ESAO Congress; OCT 5-8, 2005; Bologna, ITALY. [Poster]

 

Jung, A; Krisper, P; Haditsch, B; Stauber, R; Holzer, H; Schneditz, D Contribution of high flux dialysis to bilirubin removal in extracorporeal liver support therapy.
Artificial Organs2005; 29(9):773-774.-XXXII Annual ESAO Congress; OCT 5-8, 2005; Bologna, ITALY. [Poster]

 

Jung, A; Krisper, P; Haditsch, B; Stauber, R; Holzer, H; Schneditz, D Bilirubin kinetics for quantification of extracorporeal liver support.
7th International Symposium on Albumin Dialysis; SEP 23-25, 2005; Rostock-Warnemünde, GERMANY. 2005. [Poster]

 

Krisper, P; Stadlbauer, V; Haditsch, B; Holzer, H; Trauner, M; Stauber, RE; Schneditz, D The bilirubin/albumin ratio does not influence the clearance of conjugated bilirubin in extracorporeal liver support (ELS)
NEPHROL DIALYSIS TRANSPLANT. 2005; 20: V117-V117.-42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA); JUN 04-07, 2005; Istanbul, TURKEY.
Web of Science

 

Schneditz, D; Haditsch, B; Mekaroonkamol, P; Stauber, R Measurement of indocyanine green (ICG) elimination during extracorporeal liver support (ELS) therapy.
ASAIO Journal2005; 51(2):61A-61A.-51st Annual Conference of the American Society for Artificial Internal Organs; JUN 9-11, 2005; Washington, DC. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2005; Maikammer, Deutschland. 2005. [Oral Communication]

 

Ferenci, P; Formann, E; Gschwantler, M; Laferl, H; Brunner, H; Hackl, F; Hubmann, R; Stauber, R; Gangl, A Prospective evaluation of the 24 hour interferon (IFN) induced decline in hepatitis C virus genotype 1 load to predict sustained virologic response (SVR) to peginterferon-alfa2a/ribavirin combination therapy with or without amantadine
J HEPATOL 2004 40: 141-141. Doi: 10.1016/S0168-8278(04)90476-X
Web of Science FullText FullText_MUG

 

Ferenci, P; Formann, E; Laferl, H; Gschwantler, M; Hackl, F; Brunner, H; Datz, C; Stauber, R; Munda, P; Gangl, A Randomized, controlled, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) (Pegasys (R)) plus ribavirin (Copegus (R)) and amantadine (AMA) or placebo in patients with chronic hepatitis C genotype 1 infection.
HEPATOLOGY 2004 40: 396A-396A.
Web of Science

 

Klade, CS; Otava, O; Vytvytska, O; Zauner, W; Buschle, M; Stauber, R; Wedemeyer, H A comprehensive analysis of the T-cell response against conserved regions of HCV genotypes 1, 2 and 3
HEPATOLOGY 2004 40: 695A-695A.
Web of Science

 

Krisper, P; Stauber, R; Haditsch, B; Trauner, M; Holzer, H; Schneditz, D Mars versus prometheus: Comparison of reduction ratios (RR) as a measure of treatment dose in two different liver detoxification devices
J HEPATOL. 2004; 40: 69-70.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90216-4
Web of Science FullText FullText_MUG

 

Krisper, P; Stauber, R; Haditsch, B; Trauner, M; Holzer, H; Schneditz, D MARS versus Prometheus: Comparison of clearances as a measure of efficiency in two different liver detoxification devices
GASTROENTEROLOGY. 2004; 126: A706 -A706 .
Web of Science

 

Vogel, W; Brunner, H; Lin, W; Stauber, R; Gschwantler, M; Stadler, B; Ulmer, H Two-weeks induction therapy with pegylated interferon decreases early viral load without improving sustained virological response rate in patients with chronic hepatitis C - Prospective, randomized, open label phase III clinical trial
GASTROENTEROLOGY. 2004; 126(4): A694-A694.
Web of Science

 

Ferenci, P; Michael, G; Laferl, H; Brunner, H; Jessner, W; Hackl, F; Formann, E; Stauber, R; Hubmann, R Prospective evaluation of the 24 hour interferon-induced decline in hepatitis C virus genotype I load to predict response to peginterferon-alfa2a/ribavirin combination therapy
GASTROENTEROLOGY. 2003; 124(4): A767-A767. Doi: 10.1016/S0016-5085(03)83876-3
Web of Science FullText FullText_MUG

 

Ferenci, P; Jessner, W; Hackl, F; Gschwantier, M; Brunner, H; Hellmich, B; Laferi, H; Stauber, R; Hubmann, R; Datz, C Prediction of early virologic response to treatment with 40KD pegylated (PEG)-interferon (IFN) alfa2a/ribavirin in patients with chronic hepatitis C (genotype 1)
GASTROENTEROLOGY. 2002; 122(4): 81
Web of Science

 

Jessner, W; Hackl, F; Stauber, R; Datz, C; Kessler, H; Ferenci, P Treatment with 40 kd pegylated (PEG)-interferon (IFN) alfa2a may overcome primary IFN-resistance in patients with chronic hepatitis C (genotype 1)
J HEPATOL 2002 36: 17-17. Doi: 10.1016/S0168-8278(02)80045-9
Web of Science FullText FullText_MUG

 

Vogel, W; Brunner, H; Lin, W; Stauber, R; Ptacek-Wegerer, K; Gschwantler, M; Stadler, B Measurement of viral interferon sensitivity in patients with chronic Hepatitis C. Prospective, randomised, open label phase III clinical trial
J HEPATOL 2002 36: 135-136. Doi: 10.1016/S0168-8278(02)80486-X
Web of Science FullText FullText_MUG

 

Ferenci, P; Stauber, R; Hackl, F; Jessner, W; Hegenbarth, K; Munda-Steindl, P; Kessler, H Viral kinetics on treatment with pegylated (PEG 40 kd) interferon (IFN) alfa2a in patients infected with HCV subtype 1
JOURNAL OF HEPATOLOGY. 34: 131-132.
Web of Science

 

Jessner, W; Stauber, R; Hackl, F; Munda-Steindl, P; Kessler, H; Ferenci, P Effect of pegylated (PEG 40kd) interferon (IFN)alpha-2a on early virus elimination in patients infected with HCV subtype 1
GASTROENTEROLOGY 2001 120: A29-A29.
Web of Science

 

Stauber, R; Munda-Steindl, P; Hackl, F; Schuutze, K; Datz, C; Hofer, H; Hegenbarth, K; Jessner, W; Ferenci, P Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin
J HEPATOL. 2001; 34: 134-135.
Web of Science

 

Steindl-Munda, PE; Jessner, W; Vogel, W; Datz, C; Brunner, H; Stauber, R; Ferenci, P High dose interferon induction therapy does not improve response to combination therapy in relapsers and nonresponders to previous interferon monotherapy
J HEPATOL. 2001; 34: 166-166.
Web of Science

 

Trauner, M; Fickert, P; Zollner, G; Stauber, RE; Krejs, GJ Molecular basis of bile formation and cholestasis
In: Acalovschi, M; Paumgartner, G editor(s).FALK SYMPOSIUM; HEPATOBILIARY DISEASES: CHOLESTASIS AND GALLSTONES; JUN 09-10, 2000; CLUJ-NAPOCA, ROMANIA. DORDRECHT: KLUWER ACADEMIC PUBL; 2001. p.3-20.

 

Vogel, W; Brunner, H; Stauber, R; Lin, W; Gschwantler, M; Stadler, B Measurement of viral interferon sensitivity in patients with chronic hepatitis C prospective, randomised, open label phase III clinical trial.
HEPATOLOGY 2001 34: 337A-337A.
Web of Science

 

Ferenci, P; Berr, F; Caca, K; Firneisz, G; Szalai, F; Datz, C; Stauber, R; Vogel, W; Polli, C Phenotypic-genotypic correlations of common mutations in European patients with Wilson disease.
HEPATOLOGY 2000 32: 1023-1023.
Web of Science

 

Ferenci, P; Stauber, R; Hackl, F; Schuetze, K; Bauer, B; Datz, C Treatment with amantadine plus ribavirin plus interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy.
GASTROENTEROLOGY 2000 118: A1437-A1437.
Web of Science

 

Stauber, R; Hackl, F; Schutze, K; Bauer, B; Datz, C; Hubmann, R; Ferenci, P Successful triple combination treatment of patients with chronic hepatitis C not responding to interferon plus ribavirin
J HEPATOL. 2000; 32: 184-184. Doi: 10.1016/S0168-8278(00)81032-6
Web of Science FullText FullText_MUG

 

Stauber, RE; Hegenbarth, KS; Hackl, F; Hofer, H; Munda-Steindl, P; Ferenci, P Triple combination treatment of chronic hepatitis C is effective in nonresponders to interferon plus ribavirin.
HEPATOLOGY 2000 32: 558A-558A.
Web of Science

 

Stauber, RE; Hegenbarth, KS; Maurer, U; Kroisel, PM; Fickert, P; Trauner, M No evidence for teratogenic effects of ribavirin: Report of two cases.
HEPATOLOGY 2000 32: 1639-1639.
Web of Science

 

Stauber, RE; Hegenbarth, KS; Tiran, A; Höfler, G; Zatloukal, K; Stenzel, HC Phenotypic screening for hemochromatosis in 4000 Austrian military recruits.
HEPATOLOGY 2000 32: 1320-1320.
Web of Science

 

Trauner, M; Zenz, R; Fickert, P; Kenner, L; Stauber, RE; Denk, H; Zatloukal, K Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis.
HEPATOLOGY 1999 30: 467A-467A.
Web of Science

 

Heinemann, A; Horina, G; Pertl, C; Stauber, RE; Peskar, BA Vasopressin potentiation of adrenoceptor-mediated vasoconstriction: Functional evidence for a novel receptor of vasopressin in the rat mesenteric artery
NAUNYN-SCHMIED ARCH PHARMACOL 1998 358: R235-R235.
Web of Science

 

Heinemann, A; Horina, G; Stauber, RE; Peskar, BA Different receptor mediation of direct vasoconstriction and potentiation of adrenoceptor-mediated pressor responses by vasopressin in the rat isolate mesentery
BRIT J PHARMACOL 1998 123: U163-U163.
Web of Science

 

Kenner, L; Stumptner, C; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Tau overexpression in human alcoholic liver disease.
HEPATOLOGY 1998 28: 512A-512A.
Web of Science

 

Kenner, L; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Overexpression of keratin-8 and -18 RNA associated with mallory body formation in patients with alcoholic hepatitis.
HEPATOLOGY 1998 28: 303A-303A.
Web of Science

 

Nachbaur, K; Schlogl, A; Hackl, F; Stauber, R; Hubmann, R; Allinger, S; Datz, C; Vogel, W Prospective randomized open level study comparing two dose levels of interferon-alpha 2a according to the level of viremia.
HEPATOLOGY 1998 28: 704A-704A.
Web of Science

 

Stauber, RE; Trauner, M; Fickert, P Soreness of mucosal membranes in patients receiving interferon-alpha plus ribavirin for treatment of chronic hepatitis C.
HEPATOLOGY 1998 28: 704A-704A.
Web of Science

 

Eferl, R; Kenner, L; Fickert, P; Stauber, R; Denk, H; Zatloukal, K Validation of quantitative reverse transcription polymerase chain reaction for analysis of gene expression in liver biopsies.
HEPATOLOGY 1997 26: 1496-1496.
Web of Science

 

Ferenci, P; Stauber, R; Hackl, W; Datz, C; Gschwantler, W; Steindl, P A prospective, randomized controlled trial of high dose interferon-alpha plus ribavirin in interferon-nonresponders with chronic hepatitis C.
HEPATOLOGY. 1997; 26(4): 1148-1148.
Web of Science

 

Heinemann, A; Horina, G; Pertl, C; Peskar, BA; Stauber, RE Functional evidence for a novel vascular receptor of vasopressin in the rat
NAUNYN-SCHMIED ARCH PHARMACOL 1997 356: 43-43.
Web of Science

 

Kessler, HH; Pierer, K; Fickert, P; Stauber, RE Virological and biochemical response to combined interferon-alpha plus ribavirin therapy in patients with chronic hepatitis C.
GASTROENTEROLOGY 1997 112: A1300-A1300.
Web of Science

 

Fickert, P; Ramschak, H; Kenner, L; Hoefler, G; Hinterleitner, TA; Petritsch, W; Klimpfinger, M; Krejs, GJ; Stauber, RE Acute Budd Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation.
HEPATOLOGY 1996 24: 1534-1534.
Web of Science

 

Heinemann, A; Fickert, P; Stauber, RE The effect of vasopressin analogues on the in vitro vascular reactivity in portal hypertension
HEPATOLOGY 1996 24: 1585-1585.
Web of Science

 

Heinemann, A; Wachter, CH; Horina, G; Stauber, RE Reversal of mesenteric hyperemia in portal hypertensive rats by vasopressin analogues and water restriction.
HEPATOLOGY 1996 24: 771-771.
Web of Science

 

FERENCI, P; STAUBER, R; PROPST, A; FIEDLER, R; GSCHWANTLER, M; SCHUTZE, K; JUDMAIER, G; KREJS, GJ; GANGL, A DOSE INCREASE AUGMENTS THE RESPONSE RATE TO INTERFERON-ALPHA IN CHRONIC HEPATITIS-C
GASTROENTEROLOGY 1995 108: A1064-A1064. Doi: 10.1016/0016-5085(95)28557-1
Web of Science FullText FullText_MUG

 

HAMDANI, R; CHAPPARELLA, R; STAUBER, R; WOOD, S; KRAMER, D; ROSENBLUM, E; KONDRACKI, M; VANTHIEL, DH INTESTINAL PERMEABILITY AS MEASURED WITH POLYETHYLENE GLYCOL-600 IN PATIENTS WITH CIRRHOSIS - CLINICAL INVESTIGATION
GASTROENTEROLOGY. 1995; 108(4): A1079-A1079.
Web of Science

 

HEINEMANN, A; STAUBER, RE NITRIC OXIDE-DEPENDENT AND-INDEPENDENT VASCULAR HYPOREACTIVITY IN MESENTERIC VESSELS OF PORTAL HYPERTENSIVE RATS
HEPATOLOGY 1995 22: 1287-1287.
Web of Science

 

STAUBER, RE; JAUK, B; FICKERT, P; HÄUSLER, MCH CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) IS ELEVATED IN PREMENOPAUSAL AND IN PREGNANT-WOMEN
HEPATOLOGY 1995 22: 1550-1550.
Web of Science

 

HEINEMANN, A; TRAUNER, MH; STAUBER, RE NADOLOL INCREASES WHEREAS PROPRANOLOL REDUCES RESISTANCE IN MESENTERIC ARTERIAL BEDS OF RATS
GASTROENTEROLOGY. 1994; 106(4): A905-A905.
Web of Science

 

HEINEMANN, A; WASCHER, T; STAUBER, RE DOES ELEVATED BLOOD-GLUCOSE LEVEL MEDIATE POSTPRANDIAL SPLANCHNIC HYPEREMIA VIA NITRIC-OXIDE
HEPATOLOGY. 1994; 20(4): A356-A356.
Web of Science

 

HAMMER, HF; STAUBER, RE; KREJS, GJ EVALUATION OF THE ROLE OF FECAL SOLUTES FOR DETERMINING FECAL PH IN EXPERIMENTALLY-INDUCED DIARRHEA
GASTROENTEROLOGY. 1993; 104(4): A250-A250.
Web of Science

 

HAMMER, J; HAMMER, HF; LIPP, RW; STAUBER, RE; GANGL, A; KREJS, GJ COLONIC TRANSIT AND ITS ROLE IN CARBOHYDRATE (COH) SALVAGE CAPACITY IN LACTULOSE-(LL) INDUCED DIARRHEA
GASTROENTEROLOGY. 1993; 104(4): A251-A251.
Web of Science

 

STAUBER, RE; TRAUNER, MH; HAUSEGGER, K; PETRITSCH, W IMPROVEMENT OF LIVER-FUNCTION AFTER TRANSJUGULAR INTRAHEPATIC PORTASYSTEMIC SHUNT (TIPS) IN A PATIENT WITH CHRONIC BUDD-CHIARI SYNDROME
HEPATOLOGY. 1993; 18(4): A344-A344. Doi: 10.1016/0270-9139(93)92899-B
Web of Science FullText FullText_MUG

 

TRAUNER, MH; HEINEMANN, A; STAUBER, RE EFFECT OF PROPRANOLOL ON PRESSOR-RESPONSES TO NOREPINEPHRINE IN MESENTERIC ARTERIAL BEDS OF NORMAL AND PORTAL HYPERTENSIVE RATS
HEPATOLOGY. 1993; 18(4): A287-A287. Doi: 10.1016/0270-9139(93)92672-M
Web of Science FullText FullText_MUG

 

GASSER, R; DUSLEAG, J; REISINGER, E; STAUBER, R; FEIGL, B; GRISOLD, M; BRUSSEE, H; PONGRATZ, S; LUHA, O; KLEIN, W REVERSIBILITY BY CEFTRIAXONE OF DILATED CARDIOMYOPATHY ASSOCIATED WITH BORRELIA BURGDORFERI INFECTION
CIRCULATION. 1992; 86(4): 807-807.
Web of Science

 

HAMDANI, R; CHAPARALA, R; STAUBER, RE; ROSENBLUM, E; HONDROUDAKI, J; WOOD, S; KRAMER, D; GAVALER, JS; VANTHIEL, DH PEG 600 ABSORPTION AND URINARY-EXCRETION IDENTIFIES CIRRHOTICS LIKELY TO DIE DURING HOSPITALIZATION
HEPATOLOGY. 1991; 14(4): A245-A245.
Web of Science

 

PENNER, E; WESIERSKAGADEK, J; LINDNER, H; HITCHMAN, E; STAUBER, R; VANTHIEL, DH; SAUERMANN, G ANTIBODIES TO CORE HISTONE H3 - A SEROLOGIC MARKER FOR PRIMARY SCLEROSING CHOLANGITIS
HEPATOLOGY. 1990; 12(4): 958-958.
Web of Science

 

ROSENBLUM, ER; STAUBER, RE; BASISTA, MH; HONDROUDAKI, JE; GAVALER, JS; FUNG, J; STARZL, TE; VANTHIEL, DH CHOLESTEROL-BIOSYNTHESIS IN FK506 TREATED MALE-RATS
HEPATOLOGY. 1990; 12(4): 910-910.
Web of Science

 

STAUBER, RE; GAVALER, JS; VANTHIEL, DH FEMINIZATION IS A CONSEQUENCE OF PORTAL-SYSTEMIC SHUNTING (PSS)
HEPATOLOGY. 1989; 10(4): 722-722.
Web of Science

 

STAUBER, RE; TAUXE, WN; VANTHIEL, DH OVERESTIMATION OF PORTAL-SYSTEMIC SHUNTING IN PORTAL HYPERTENSIVE RATS BY SPLENIC INJECTION OF MICROSPHERES
HEPATOLOGY. 1989; 10(4): 586-586.
Web of Science

 

PRISTAUTZ, H; PETRITSCH, W; SCHREIBER, F; EBER, B; SOMMERSGUTTER, M; PFNISS, G; STAUBER, R INVITRO MEASUREMENT OF THE PROTECTIVE EFFECT OF SUCRALFATE ON HUMAN GASTRIC-MUCOSA
Z GASTROENTEROL. 1987; 25(8): 538-538.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum